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ABSTRACT 
In this study, two lectins, (designated TML-1 and TML-2) and a 
polysaccharide-peptide complex (designated TMP) were isolated from the 
mushroom Tricholonia morigoHcinn which is a very famous edible wild mushroom 
found in Northern China but hardly known for its medicinal value. The 
immunomodulatory and antitumor activities of the two lectins and TMP, as well as 
the hypotensive effects ofTML-1 were investigated. 
TML-1 and TML-2, were isolated from T. nioiigoIicum by ion exchange 
chromatography and gel filtration. They were dimers with molecular weights of 
about 37,000. The hemagglutinating activities of TML-1 and TML-2 toward 
rabbit erythrocytes were sensitive to lactose inhibition and were stable between 
10°C and 80°C. The two lectins differed in the content of proline and tyrosine 
residues. Both were nonglycoproteins and possessed hydroxyproline residues. 
They did not differ appreciably in their pH stability and cationic requirement for 
hemagglutinating activity. They exhibited antiproliferative activities against mouse 
monocyte-macrophage PU5-1.8 cells and mouse mastocytoma P815 cells but did 
ii 
not inhibit the growth of mouse Sarcoma 180 and monocyte-macrophage P388D1 
tumor cell lines in vitro. 
The two lectins stimulated the production of tumor necrosis factor and 
nitrite ions by activated macrophages in the mice. TML-1 and TML-2 were able to 
inhibit the growth of implanted Sarcoma 180 cells in mice by 68.8% and 92.4% 
respectively. They exhibited slight mitogenic activity toward T-cells or splenocytes 
from the normal mice in vitro when compared with concanavalin A. However, the 
proliferation of T-cells from the normal and tumor-bearing mice which had been 
pretreated by an intraperitoneal injection of the lectins was inhibited. In mice the 
growth of Sarcoma 180 cells in the peritoneal cavity was inhibited and the life-
span of mice was prolonged by the administration of the two lectins. 
TML-1 exerted a hypotensive action in rats after intravenous injection via 
the jugular vein. The hypotensive changes produced by TML-1 were dose-
dependent. Administration ofTML-l at a dose of 10 mg/kg body weight caused a 
mean arterial blood pressure (MAP) reduction of 95.3±7.4 mmHg. The 
hypotensive action of TML-1 was not mediated via autonomic ganglion 
transmission, a-adrenoceptors, beta-adrenoceptors, cholinergic receptors, 
histaminergic receptors, nor the renin-angiotensin system. Rather it was probably 
mediated through vasorelaxation via adenosine A2 receptors and/or nitric oxide 
production. 
A polysaccharide-peptide complex, TMP, with immunoenhancing and 
antitumor activities，was obtained from the mycelial culture of Tricholoma 
mongoliciim. TMP possessed a molecular weight of 15,500 as estimated by gel 
iii 
filtration and a carbohydrate : protein ratio of approximately 8 : 1, and it was not 
adsorbed on DEAE-Sepharose CL-6B. TMP exhibited the activities of activating 
macrophages, stimulating proliferation of T-cells, and inhibiting the growth of 
Sarcoma 180 cells which had been implanted in mice. 
The results of the present study indicate that TML-1, TML-2 and TMP 
from T. mongolicinv deserve to be studied as potential agents for 
immunomodulation and cancer therapy. TML-1 may be used as a hypotensive 
drug after further research. T. mongoIicimi could also be developed and used as a 
nutriceutical as well as a flavor food： 
• 
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Several mushrooms have been traditionally used for the maintenance of 
health and for the prevention and treatment of diseases, including cancer, viral 
disease, hypercholesterolemia, blood platelet aggregation and hypertension (Breene, 
1990; Jong et al., 1991; Mizuno et al., 1995a). Many of the active substances which 
include polysaccharides, nucleic acid derivatives, lipids, peptides, proteins and 
glycoproteins, have been isolated and identified. Some of the mechanisms of 
biological activities have been elucidated (Hajto et al., 1990; Hirotani and Fuaiya, 
1990; Chihara, 1992; Kraus et al., 1992; Ochiai et al., 1992; Liu et aI., 1993a; Wang 
et al., 1995a). 
Lectins are generally defined as proteins or glycoproteins with specific 
binding sites for sugars which are not antibodies or enzymes (Goldstein et al. 1980). 
They occur in a variety of viruses, bacteria, fungi, plants, animals and in man. They 
• 
attract considerable interest because they selectively recognize a large number of 
• 
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oligosaccharide structures synthesized by living organisms (Sharon and Lis, 1972, 
1989; Stockert et al., 1974; Peumans et al., 1984; Summerfield and Taylor, 1986; 
Van Damme et al., 1987; Broekaert et al., 1989; Osborn et al., 1989; Allen et aI., 
1991). Microbial lectins aid in the attachment of microorganisms to target cells, 
whereas animal lectins are involved in intercellular communication and in the 
phagocytosis and destruction of microorganisms. Because of their carbohydrate-
binding specificities, lectins have become useful tools in studies of cell surface 
structures. They have also been used as ligands in affinity chromatography for the 
purification of biological materials that contain carbohydrates and in structural 
studies of oligosaccharides or carbohydrate moieties of glycoproteins (Sharon and 
Lis, 1989; Lis and Sharon, 1993; Kennedy et al., 1995). 
Many lectins possess immunomodulatory and antitumor properties (Lin et al., 
1970; Hajto et al., 1989; Ko et al., 1995). For example, a P-galactoside-specific 
lectin from mistletoe extract exhibits immunomodulatory potency ui vivo. It induces 
increased secretion of tumor necrosis factor a (TNFa), interIeukin 1 (IL-1) and 
interleukin 6 (IL-6) in cultures of human peripheral blood mononuclear cells and 
increases the level of cytokines (TNP-a and IL-6) in semm of the cancer patients 
after an injection of the lectin (Hajto et al., 1990). 
More than 25 lectins have been isolated and purified from mushrooms 
(Kogure, 1975; Horejsi and Kocourek, 1978; Kawagishi et al., 1988; Kawagishi, 
1995; Konska et al., 1994). Some of them enhance the immune system of animals 
and inhibit the proliferation of several tumor cell lines in vifro and in vivo. For 
• 
instance, Agaricus hisponis lectin reversibly inhibits proliferation of epithelial cell 
2 
lines (Yu et al., 1993), Volvariella volvacea lectin has a moderate inhibitory effect 
on the growth of Sarcoma 180 cells in vivo (Lin and Chou, 1984), Grifola frondosa 
lectin is cytotoxic against Hela cells (Kawagishi et al., 1990), and a new fungal 
_ V 
immunomodulatory protein has been isolated from the edible mushroom Flammulina 
velutipes (Ko et al., 1995). 
Some edible mushrooms have been reported to demonstrate hypotensive 
effects. The aqueous extract or powder of the fruiting body of mushroom exhibits a 
hypotensive property in animals (Tam et al., 1986; Breene, 1990; Chiu et al., 1995). 
Several lectins manifest hypotensive activity. Four plant lectins, namely wheat germ 
agglutinin, concanavalin A, lentil agglutinin and ricin, have been shown to relax the 
coronary arterial and/or aortic rings. (Kleha et al., 1991; 1993). 
Studies on the polysaccharides of edible mushrooms with immunomodulatory 
and antitumor activities have been carried out extensively, such as schizophyllan 
from Schizophylhmi comnmm (Ohno et al., 1995), lentinan from Lentinus edodes 
(Chihara, 1992; Ochiai et al., 1992), polysaccharide krestin (PSK) and 
polysaccharopeptide (PSP) from Coriolus versicolor (Tsukagoshi et al., 1984; 
Sakagami et al., 1991; Yang et al., 1992)，a polysaccharide-peptide complex (PSPC) 
from Tricholoma sp. (Wang et al., 1995a; Liu et al., 1995) and several 
polysaccharides or protein-bound polysaccharides have been identified (Chang et al., 
1988; Jong et al., 1991; Mizuno et al., 1995a). 
In the present study, an edible mushroom in Northern China, Tricholoma 
mongolicum (Imai.) was investigated in the search for some active substances which 
possess immunomodulatory, antitumor or other biological activities. T. mongolicum 
3 
belongs to Basidiomycotina, Hymenomycetes, Aga.ricales, Tricholomataceae. In the 
summer of each year, the fruiting bodies of T. mmigoliami appear on the grasslands 
and form a fairy ring in Northern region of Hebei province and Inner Mongolia. T. 
mongolicnm exhibits special flavor and is a very famous edible wild mushroom (Ying 
et al., 1988; Mao, 1993). However, its medicinal value is hardly known. In the 
present study, the lectins and polysaccharide-peptide complex were extracted and 
purified from the cultured mycelium of this mushroom and their general 
characteristics, immunomodulatory, antitumor and hypotensive activities 
determined. The immunomodulatory activities studied included mitogenic response 
against T-cells and splenocytes from the mice, ability to activate the peritoneal 
macrophages for their cytotoxicity against the tumor cells directly and the 
production of tumoricidal substances such as tumor necrosis factor and nitrite ions. 
The antitumor activities studied included antiproliferative activity against tumor cells 
in vitro and in vivo. The hypotensive activity of T. niofigoJiciun lectins was 









2.1.1. Aspects oflectins 
A lectin (from the Latin le^cre. to choose) is a glycoprotein, sugar-binding 
protein or protein of non-immune origin which agglutinates cells and/or precipitates 
glycoconjugates (Goldstein et al., 1980). Lectins bear at least two sugar-binding 
sites and agglutinate animal and plant cells (most commonly erythrocytes, 
unmodified or enzyme-treated). The specificity of a lectin is usually defined in terms 
of the iTiono-saccharide(s) or simple oligosaccharides that inhibit lectin-induced 
agglutination (or precipitation or aggregation) reactions. Lectins are widely 
distributed in plants, fungi, bacteria, viruses and animals. Because the first was 
discovered in plants, they are also called plant agglutinins, phytoagglutinins, or 
• 
phytohemagglutinins (Goldstein et al., 1980; Sharon and Lis, 1989; Drickamer and 
5 
Taylor, 1993). The phenomenon of hemagglutination by a saline extract from the 
beans of Ricinus commimis was first reported in 1888，termed ricin (Kennedy et al., 
1995). The extract was capable of agglutinating erythrocytes from various animals 
and man to different degrees. Soon after the discovery of ricin, another lectin, abrin, 
was found in the beans of Abnis precatorius (Roth, 1978). In 1891 these two toxic 
lectins were used in studies on immunity which led to the discovery of the specificity 
of antibodies (Hornets, 1990). In fact, the first investigations of lectin-containing 
seeds were aimed at elucidating toxic principles of the plant materials used for 
medicinal purposes. Twenty years after the discovery of the toxic lectins, nontoxic 
lectins were isolated from Phaseolus vulgaris, Pisum sativum. Lens adinahs and 
Vicia sativa. Like ricin and abrin, the nontoxic lectins were used in immunology for 
stimulation of antibody production (Sharon and Lis, 1972). The start of the modern 
era of lectin investigation can be traced back to the first application of a chemically 
well-defined afFinity carrier for isolation of concanavalin A (Con A) in the mid-1960s 
(Agrawal and Goldstein, 1965). Affinity chromatography of lectins has opened the 
way for both extensive and intensive research of these substances at a molecular 
level and for their wider applications (Beuth et al., 1995; Kennedy et al., 1995). 
The interactions of lectins with cells can, in many instances，be inhibited 
specifically by simple sugars (Ersson et al., 1973; Ng et al., 1989; Dong et al., 1993). 
This finding has led to the conclusion that lectins bind specifically to saccharides on 
the surface of cells, and has provided a new tool for the investigation of the 
architecture of cell surfaces. Lectins also bind to mono- and oligosaccharides and 
specifically precipitate polysaccharides and glycoproteins. The precipitation is 
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inhibited by sugars, as in the case Of the agglutination reaction. This property of 
lectins can be used for the isolation and purification of carbohydrate-containing 
polymers, and for the study of their chemical structure (Watkins and Morgan, 1952; 
Nagata and Burger, 1974; Nachbar et al., 1976; Shibuya et al., 1987; Taylor and 
Summerfiled, 1987; Sharon and Lis, 1989; Ching and Rhodes, 1990; Woo et al., 
1991; Duk et al., 1992; Plendl et al., 1993; Iobst et al., 1994). 
Some lectins preferentially agglutinate mammalian tissue culture cells that 
have been transformed by oncogenic viruses or by chemical carcinogens, as well as 
spontaneously transformed cells (Sharon and Lis, 1972; Gabius and Gabius, 1991). 
These and related findings indicate that the surface of a transformed cell differs from 
that of its untransformed counterpart, and raise the hope that studies with lectins 
may lead to a better understanding of cancer. Moreover, they have prompted 
investigators to use lectins as inhibitors of growth of malignant cells in vitro and in 
vivo, and lectin-binding synthetic polymers for the immunization of mice against 
tumors (Sharon and Lis, 1989; Kennedy et al., 1995). Lectins have become useful 
tools in the structural studies of the cell surface, oligosaccharides and/or 
carbohydrate moieties of glycoproteins (Katoh et al., 1993; Leung et al., 1993; 
Konska et al., 1994). Changes in glycosylation which occur during the steps of 
malignant transformation are well-known. The recognition of the difference between 
normal and transformed cells and the adhesion of metastasizing tumor cells may be 
used to diagnose the malignant cells and inhibit tumor metastasis in the future (Beuth 
et al., 1995; Schumacher，1995). 
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2.1.2. Isolation and purification oflectins 
Lectins can be isolated from plant extracts or other sources by several 
techniques (Kennedy et al., 1995). In ion exchange chromatography proteins are 
adsorbed to the matrix, mainly due to ionic interaction with the adsorbent. 
Disruption of interactions by pH dependent modifications, or by agents competing 
with the absorbents' charged groups lead to the release of proteins into distinct 
fractions, dependent on the binding of each sample component to the matrix. 
Exchangers such as DEAE-cellulose, CM-cellulose, CM-Sephadex, DEAE-
Sephadex, SP-Sephadex and DEAE-Sepharose have been successfully used. 
Molecular exclusion chromatography is based on percolation of a protein sample in 
the pores of inert matrices of controlled porosity such as crosslinked dextran and 
polyacrylamide, amongst others, with subsequent separation of the components by 
differential elution, according to the molecular size (Franz, 1986; Yeung, et al., 
1986). 
Affinity chromatography is one of the most powerful techniques for protein 
purification and its application is mainly based on the protein's ability to bind 
carbohydrates in a specific and reversible way (Kennedy et al., 1995). Different 
affinity matrices for lectins are chosen according to the lectin specificity to 
carbohydrates, which can be defined through inhibition assays of the 
hemagglutinating activity, by using simple monosaccharides or complex 
carbohydrates, such as Con A binding to Sephadex G-50, -75，-100 and -200 
because its specificity is a-mannose/a-glucose. Lectins with a specificity to N-
acetyl-D-glucosamine and its oligosaccharides can be isolated using chitin as an 
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affinity matrix. The lectins specific to galactose and its derivatives can be 
differentially purified using agarose, Sepharose and acid-treated Sepharose. Several 
affinity matrices have been prepared by coupling carbohydrates or glucoproteins to 
different supports. Desorption of affinity matrices has been performed 
biospecifically, using the competing carbohydrate or non-biospecifically by changing 
the pH or ionic strength. For example, adsorbed Con A has been eluted from 
Sephadex with glucose, D-fructose, D-mannose, sucrose and methyl-P-D-
glucopyranoside (Horejsi and Kocourek, 1978; Ng et al., 1986; Kawagishi et al., 
1990). 
Among the high resolution techniques used to obtain pure lectins are FPLC 
and HPLC. The surface lectin of pathogenic Entamoeba histolytica was isolated by 
affinity chromatography followed by anion exchange chromatography on a Mono Q 
HR column using the FPLC system. HPLC can be utilized for molecular weight 
estimation of purified lectins, for protein fractionation and for separation of peptide 
fragments obtained by digestion of purified lectins by endoproteinases (Kawagishi et 
al., 1994; Konska et al., 1994). 
2.1.3. Characteristics oflectins 
Some chemical characteristics of several highly purified lectins are shown in 
Table 2.1 (Sharon and Lis, 1972; Lotan et al., 1975; Roth, 1978; Matsumoto et al., 
1983). Most of the purified lectins contain covalently bound sugars, and can thus be 
classified as glycoproteins. But a few oflectins, for example concanavalin A which is 
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devoid of sugar residues, are not glycoproteins. The carbohydrates found in lectins 
include mannose, glucosamine, galactose and xylose. 
Most lectins are relatively rich in aspartic acid, serine and threonine which 
may comprise as much as 30 percent of their amino acid contents and are very low 
in, or completely devoid of, sulfur-containing amino acids. In the snail lectin, aspartic 
acid and serine are the most abundant amino acids, and significant amounts of 
cysteine and methionine are also present. Cysteine is also found in the lectins of the 
meadow mushroom {Agaricus campestris) (Sage and Connett, 1969)，the lima bean 
{Phaseolns limatiis) and the horseshoe crab {Linmlus polypheiniis) (Sharon and Lis, 
1972; Horejsi and Kocourek, 1978). 
2.1.4. Effects oflectins on biological activities 
The specificity oflectins proves to be much more exquisite recognitions since 
they not only distinguish between different monosaccharides, but also specifically 
bind to oligosaccharides, detecting subtle differences in complex carbohydrate 
structures (Sharon and Lis, 1989). Recognition is a central event in a variety of 
biological phenomena and the first step in the numerous processes based on cell-cell 
interactions, such as cell migration, organ formation, immune defense and microbial 
infection. Improper functioning of cell recognition may cause disease. Thus, defects 
ofleukocyte and platelet adhesion result in recurring bacterial infections and mucosal 
bleeding, respectively. Furthermore, aberrant cell recognition is thought to underlie 
the uncontrolled cell growth and motility that characterize neoplastic transformation 
and metastasis. An understanding of the molecular basis of the cell-surface code, 
10 
therefore, has implications for intervention in many areas of biology and medicine 
(Walker, 1990’ 1993; Drickamer and Taylor, 1993; Mackay and Imhof, 1993). 
It is well established that almost all cells carry carbohydrates on their surfaces 
in the form of glycoproteins, glycolipids, and polysaccharides (Stryer, 1975, 1988; 
Roth, 1978). The carbohydrates have an enormous potential for encoding biological 
information. Cells may interact via bridges formed by soluble glycoproteins that bind 
to the cell surface lectins. Alternatively, the lectins may combine with carbohydrates 
of insoluble components of the extracellular matrix that promote cell-substrate 
adhesion. In addition, soluble lectins may act as bridges by binding to carbohydrates 
on apposing cells. The carbohydrate binding sites of lectins recognize and adjust to 
the ligand carbohydrate through a lock and key type mechanism, involving complex 
networks of hydrogen bonds. The formation of a carbohydrate-protein complex 
involves the displacement of water molecules associated with the protein polar 
groups and around the highly polar sugar, with the establishment of new hydrogen 
bonds; these latter bonds and Van der Waals contacts are the dominant forces in 
binding stability (Varki, 1992; Kennedy et al., 1995). 
2.1.4.1. The role of lectins in plant defence 
Most plant lectins can be regarded as storage proteins which, in addition, 
have a potential defensive role when the plant or the seed is attacked. As long as the 
plant or seed is not challenged, the lectin does not fulfil any defensive role but is 
simply used as a storage protein. Such a double role is certainly advantageous for the 
plant from an evolutionary point of view (Peumans and Van Damme, 1995). 
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Ricin, abrin and mistletoe lectin 1 are a group of cytotoxic lectins that 
undoubtedly play a role in the defence of plants. They consist of two chains, A and B 
chains. The B-chain of these lectins binds to receptors on the surface of cells and 
promotes the uptake of the A-chain into the cell (Refsnes et al., 1974; Franz, 1986). 
After the A-chain enters the cell, it inactivates catalytically all eukaryotic ribosomes 
by its highly specific N-glycosidase activity which cleaves the N-glycosidic bond of 
the adenosine residue (Stirpe and Barbieri, 1986; Yeung et al., 1988). Plants that 
accumulate proteins of this type are extremely toxic for all eukaryotes and, in 
principle, are completely protected against attack by any eukaryote organism 
(Barbieri et al.，1979). 
A potential role for lectins in the defence of plants against insect attack has 
been recognized (Janzen et al., 1976). However, intensive screening oflectins from a 
wide variety of sources for their anti-insect properties and their structural studies 
have only started in the last few years (Beintema and Peumans, 1992; Lerner and 
Raikhel, 1992). Feeding trials with both artificial seeds and diets containing varying 
levels of different lectins have demonstrated that many lectins are toxic for one or 
more insect species and that the spectrum of insects sensitive to a particular lectin is 
highly variable. For example, a mannose-binding snowdrop {Galanthys nivalis) 
lectin is toxic not only for some chewing insects but also for sucking insects like 
aphids and leafhoppers (Peumans and Van Damme, 1995). 
Because of their specificity, chitin-binding lectins seem to be predestined to 
play a protective role against fUngal attacks. The two small chitin-binding lectins 
from Urtica dioica and Hevea brasiliemis respectively, have been shown to possess 
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antifungal properties and therefore can be considered as plant protective agents 
(Mirelman et al., 1975; Gatehouse et al., 1995). 
2.1.4.2. The specificity of some legume lectins 
Some lectins from legumes serve as mediators of the symbiosis between 
nitrogen-fixing microorganisms, primarily rhizobia, and leguminous plants, a process 
of immense importance in both the nitrogen cycle of ecosystem and in agriculture 
(Brock and Madigan, 1991). The association between legumes and nitrogen-fixing 
bacteria is highly specific. For example, rhizobia that infect and nodulate soybeans 
cannot nodulate garden peas or white clover and vice versa. The idea that lectins are 
responsible for this association is initially based on the finding that a lectin from a 
particular legume, for example soybean agglutinin, binds in a sugar-specific manner 
to the corresponding rhizobial species and not to bacteria that are symbionts ofother 
legumes (Bohlool and Schmidt, 1974; Sharon and Lis, 1989). There is convincing 
evidence in favor of the lectin recognition hypothesis in the symbiosis between the 
white clover Trofolium repetis, and Rhizohiuni trifoIii. A lectin (trifoliin A) specific 
ifor 2-deoxyglucose is isolated from the extracts of clover seeds and seedling roots. It 
binds to infective, but not to uninfective, strains of rhizobia. Antibodies to the lectin 
bind mostly to the root hair region of clover roots but do not bind to the roots of 
others closely related legumes, for example, alfalfa. The lectin is related to the roots 
by the sugar for which it is specific, suggesting that it associates with the root 
surface via its carbohydrate-binding site. Trifoliin may thus act as a bridge between 
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similar carbohydrates on both the root hair tips and R. trifolii. A polysaccharide that 
could serve as such a receptor is present on the surface of infective strains of R. 
trifolii but absent (or inaccessible) on noninfective strains (Ho et aI., 1986; Giollant 
et al., 1993). ‘ 
2.1.4.3. Some properties of animal lectins 
Animal lectins have been grouped into classes based on the nature of their 
carbohydrate ligands, the biological processes in which they participate, their 
subcellular localization, and their dependence on divalent cations (Kilpatrick, 1995). 
Classification based on shared sequence characteristics is now one of the most useful 
ways to sort the lectins. While the overall architecture of the lectin proteins varies 
widely, carbohydrate-binding activity can often be designated the carbohydrate-
recognition domain (CRD). The animal lectins have been classified to three types. 
They are C-type, S-type and N-type lectins (Drickamer and Taylor, 1993; Barondes 
etal.，1994a, 1994b). 
The C-type (Ca^.-dependent) lectins derive their name from the fact that they 
require calcium ions for activity. In addition, they are all extracellular, although they 
bind to a diversity of sugars. These proteins contain a characteristic carbohydrate-
binding domain with a framework sequence of 18 highly conserved amino acid 
residues (Drickamer, 1992; Weis et al., 1992; Gordon, 1994; Holmskov et al., 1994; 
Iobst and Drickamer, 1994). 
S-type (sulfadryl-dependent) lectins, also called galaptins or soluble P_ 
galactoside-binding lectins, form a large family with highly conserved primary 
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structures and carbohydrate specificity. They are found both inside and outside cells. 
General features of the family include specificity for N-acetyllactosamine, and 
inactivation upon oxidation necessitating the presence of reducing agents like 2-
mercaptoethanol or dithiothreitol during isolation and storage (t)rickamer, 1988; 
Liu, 1993). 
N-type 0Sfon-C and Non-S type) lectins do not constitute a family but rather 
consist of a miscellany of unrelated molecules which share only the feature of being 
able to bind to some carbohydrate structures (Kilpatrick, 1995). 
A. As a mediator ofbinding and phagocytosis 
A novel role ascribed to the mannose and N-acetylglucosamine-specific 
macrophage lectin is to act as a mediator of binding and phagocytosis (i.e. 
lectinophagocytosis) of microorganisms that carry on their surface complementary 
sugars. Examples are the phagocytosis of Aspergillus fiimigatus and Klebsiella 
pneumoniae by mouse and guinea pig alveolar macrophages, respectively, of 
Pseudomonas aeruginosa by monocyte-derived human macrophages (Kan and 
Bennett, 1988; Speert et al., 1988), and of Leishmania donovani promastigotes by 
mouse peritoneal macrophages. Macrophage membrane lectins with other 
specificities may also function in lectinophagocytosis (Blackwell et aI., 1985; Sharon 
and Lis, 1989). 
B. Control ofdifferentiation and organ formation 
Some animal lectins are able to control the differentiation and organ 
formation (Sharon, 1983). It is perhaps the main function of the ubiquitous p-
galactoside-specific lectins. Although classified as P-galactoside-specific, the 
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individual lectins examined differ markedly in their preference for different galactose-
containing oligosaccharides, indicating that perhaps no two of them are identical in 
their fine carbohydrate specificities. A p-galactoside-specific lectin is found in the 
epithelium of the mouse thymus and is postulated to be responsible for holding 
immature thymocytes in the thymic cortex by binding to galactose residues on the 
surface of these cells (Levi and Teichberg, 1984). Upon maturation of the 
thymocytes, the galactose residues become masked by attachment of sialic acid, and 
the cells lose their ability to bind the lectin. They are thus free to migrate to the 
thymic medulla, where the mature thymocytes reside, or directly to enter the 
circulatory system (Sharon and Lis, 1989). 
C. Lectins and migration oflymphocyte 
During their normal life span, lymphocytes migrate from the bloodstream into 
the lymphoid organs, such as lymph nodes and Peyer,s patches (Junqueira et al., 
1995). An adhesive interaction which involves lectins and specific carbohydrates 
between lymphocytes and the endothelium of postcapillary venules is the first step in 
this migratory or homing process. Insight into the molecular basis of the adhesive 
interaction is obtained by experiments ui vitro, which demonstrated that binding of 
both mouse and human lymphocytes to frozen sections of syngeneic lymph nodes is 
inhibited by L-fucose and mannose 6-phosphate as well as by fucoidin, a polymer of 
L-fucose, and a phosphomannosyl-rich polysaccharide from yeasts. Fucoidin also 
blocks the migration of lymphocytes into lymph nodes in vivo (Stoolman and Rosen, 
1983). Thus, the recognition between lymphocytes and the cells of the lymphoid 
organs is based on lectin-sugar interactions. The lectin has recently been purified 
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from the mouse spleen by affinity chromatography on a monoclonal antibody against 
mouse lymphocytes. It is a glycoprotein with a molecular weight of 90 K (Lasky et 
al., 1989; Sharon and Lis, 1989; Lis and Sharon, 1993). 
D. Lectins and metastasis 
The formation of secondary tumors by circulating cancer cells (blood-borne 
metastasis) correlates with an increased tendency of the cells to form emboli by 
aggregating with other tumor cells or host cells. Several lines of evidence strongly 
suggest that lectins on human and murine metastatic tumor cell surfaces may be 
involved in the formation of the emboli (Raz and Lotan, 1987). In addition, the 
lectins may facilitate adhesion of the aggregates to endothelial cells of capillaries. 
They may function by binding complementary glycoconjugates on the surface of 
other tumor cells to mediate homotypic aggregation, or on the surface of host cells 
to mediate heterotypic aggregation or attachment to endothelial cells or extracellular 
matrix (Schumacher, 1995). 
P-galactoside-specific surface lectins (with molecular weight of 14.5 and 34 
K) are present on different murine and human tumor cells, including melanoma, 
fibrosarcoma, and carcinoma (Raz and Lotan, 1987; Lotan and Raz, 1988). The 
ability of the cells to undergo aggregation to some lectins correlates well with the 
metastatic potential of the tumor cells. Highly metastatic melanoma and 
fibrosarcoma cells that have been treated with the antibody to the lectin before their 
injection into mice show significantly decreased metastatic potential. Studies with 
lectin-resistant glycosylation mutants of a highly metastatic tumor cell line have 
revealed that the loss of metastatic potential observed with some of the mutants is 
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related to some specific glycosylation defects, such as deficiency of sialic acid and 
galactose or the absence of pi-6-linked branches of N-linked complex 
oligosaccharides. Revertants that regain the wild-type glycosylation profile are again 
highly metastatic. The distribution patterns of lectins and carbohydrates on normal 
and malignant cells are being studied, in the hope of finding clear-cut differences that 
may be useful for diagnostic purposes. An intense effort is also under way to exploit 
cell surface lectins as targets for the controlled and selective delivery of drugs to 
malignant cells ( Sharon and Lis, 1989). 
Adhesion and inhibition experiments with parenchymal cells and tumor cells 
indicate that lectins mediate specific cellular interactions. Both in vitro and in vivo 
the adhesion of tumor cells to parenchymal cells can be inhibited by lectin-blocking 
glycoconjugates while non-specific glycoconjugates do not interfere with the 
adhesion process. Accordingly, when organ-characteristic lectins are blocked with 
competitive receptor analogues, tumor colonization can be significantly reduced 
(Beuth et al.，1995; Schumacher, 1995). 
2.1.4.4. Hypotensive activity of the lectins 
Several lectins can lower the blood pressure. Ricin is a toxic lectin isolated 
from the castor bean and it may lower blood pressure in rabbits (Christiansen et al., 
1994; Zhang et al., 1994). Three other plant lectins, namely, wheat germ agglutinin, 
concanavalin A and lentil agglutinin are also shown to relax the coronary arterial 
and/or aortic rings by enhancing the production of endothelium-derived relaxing 
factor (EDRF) which is a very labile compound with rapid biological action (Fukuto, 
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1995). It is believed that the major EDRF released from the endothelium is nitric 
oxide. Vascular responses to EDRF are similar to the responses of nitrovasodilators 
that both stimulate guanylate cyclase which, by increasing smooth muscle guanosine 
3':5'-cyclic monophosphate (cyclic GMP) levels, causes smooth muscle relaxation 
(Kleha et al., 1993; Christiansen et al., 1994). 
The endothelium-dependent relaxation induced by EDRF is associated with a 
rise in the cyclic GMP content of the smooth muscle cells (Ignarro et al., 1984; 
Gryglewski, 1995). Nitric oxide and compounds which probably produce their 
biological effects through formation of nitric oxide, such as glyceryl trinitrate, 
sodium nitropaisside, etc., induce smooth muscle relaxation which, although not 
mediated via endothelial cells, is also associated with the increased levels of cyclic 
GMP (Martin et al., 1985). It has been proposed that this rise in smooth muscle 
cyclic GMP content mediate relaxation by inducing a cyclic GMP-dependent 
dephosphorylation of myosin light chain (Gruetter et al., 1980; Kleha et al., 1993). 
Nitric oxide and the nitrovasodilators have, in addition, been shown to 
stimulate the activity of guanylate cyclase in homogenates prepared from several 
I 
tissues, and this stimulation appears to be blocked by the oxidant methylene blue. 
Methylene blue might produce its effects by oxidizing a component of guanylate 
cyclase, possibly a ferrous heme group linked to the enzyme molecule (Snyder, 
1992; Kleha et al., 1993; Gryglewski, 1995). 
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2.1.4.5. Lectins in immunology 
Protein-carbohydrate interactions occur in association with many biochemical 
processes. It comes as no surprise, therefore, that lectin-carbohydrate interactions 
are a common and important feature of molecular events underlying the immune 
response. Studies with lectins in the field of immunology will be considered under 
four categories: (1) lectins as polyclonal reagents to investigate the molecular basis 
of lymphocyte activation and proliferation as well as their control; (2) lectins as 
reagents to identify and/or differentiate cells of the immune system; (3) lectins as 
drugs; and (4) endogenous lectins as first-line agents of defence or as mediators of 
cellular communication within the immune system (Kilpatrick, 1995). 
A. Mitogenic response oflymphocytes to lectins 
The value of plant lectins as polyclonal activators is well-known and well-
established. The use oflectins including PHA and Con A which transform a majority 
of resting lymphocytes into lymphoblasts irrespective of antigenic specificity 
enormously facilitates studies on the biochemistry of this process. Many plant lectins 
are found to be mitogenic for animal lymphocytes, but many are not. Of those that 
are mitogenic, most are largely or exclusively active towards T-lymphocytes (Sharon 
and Lis, 1972; Horejsi and Kocourek, 1978; Dalton et al., 1995). 
It is indisputable that mitogenic lectins bind to lymphocytes via saccharide 
receptors and thereby trigger cell activation，but some non-mitogenic lectins also 
bind to lymphocytes in a similar saccharide-specific manner (Axelsson et al., 1978). 
Binding to the lymphocyte cell surface is therefore a necessary requirement of a 
mitogenic lectin, although simply binding is not enough to guarantee subsequent 
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activation. The heterogeneity of receptors for PHA, Con A and other lectins on 
lymphocytes makes it difficult to relate receptor occupancy to mitogenic activity. 
Suggestions have been made that the essential difference between mitogenic and 
non-mitogenic lectins in general is that only the former bind to the T3 (CD3) 
molecules, or to histocompatibility antigens, or to the T-cell receptors 
fKanellopoulos et al., 1985). There is also evidence that some lectins can induce a 
mitogenic response via CD2, the T-lymphocyte receptor for sheep erythrocytes, via 
an alternative pathway of activation. Studies with monoclonal antibodies of precise 
specificity have demonstrated that a large number of cell surface molecules can 
apparently influence the mitogenic process in vitro (Kilpatrick, 1995). 
If lectins can induce a mitogenic response by binding to certain T-cell 
receptors, it might be expected that other lectins or other receptors may function in 
the opposite direction (Greene et al., 1981a). Indeed, the concept of "stimulatory 
domains" and “ inhibitory domains" on the surface of the same lymphocyte has been 
proposed. However, an alternative and equally plausible possibility is that occupancy 
of the same receptor may lead to a positive or negative signal depending on the 
nature of the ligand and the precise conditions. Therefore a particular lectin might be 
mitogenic or non-motogenic depending on the circumstances. The same lectin can 
undoubtedly induce opposing effects under different circumstances. Time-honoured 
examples include the non-mitogenic activity of Con A and PHA at relatively high 
lectin concentrations (Kilpatrick, 1995). 
21 
Some lectins are certainly anti-mitogenic i.e. they inhibit the action of 
mitogens in the co-culture experiments. Examples include Agaricns bisponis lectin 
(ABL) and the potato and tomato lectins (Greene et al., 1981b; Kilpatrick, 1995). 
B. Lectins and cytokine secretion 
Cytokines are soluble substances secreted by cells, which have a variety of 
effects on other cells. When released by monocytes they are referred to as 
monokines, and when released by lymphocytes they are called lymphokines. Those 
cytokines which participate in the cellular "communication" between leukocytes are 
referred to as interleukins (Golub and Green, 1991). 
Cytokines have several features in common. They are antigen-nonspecific 
glycoproteins, synthesized and generally rapidly secreted in response to a stimulus, 
they are not stored within the cell that makes them. Cytokines are believed to act 
over a short range and to have very short half-lives (Benjamini and Leskowitz, 
1991). 
Some lectins have been reported to increase secretion of some cytokines. 
Controlled enhancement of nonspecific immune defense mechanisms can beneficially 
manipulate the host's ability to attack malignant cells (Kilbourn et al., 1984; Ohkuma 
et al., 1986). 
A P-galactoside-specific lectin from mistletoe extract (Franz, 1986) induces 
increased secretion of tumor necrosis factor a (TNFa), interleukin 1， a n d 
interleukin 6 in cultures of human peripheral blood mononuclear cells. The 
enhancement of secretion is caused by selective protein-carbohydrate interactions by 
the strict dependence on the presence of the carbohydrate-binding subunit of the 
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lectin and the reduction of the effect of the lectin in the presence of the specific 
lectin-binding sugar as well as anti-lectin antibodies. Increased cytokine levels in the 
serum of cancer patients after injection of optimal lectin dose (1 ng/kg body weight) 
corroborate the in vitro results (Hajto et al., 1990; Beuth et al., 1992). Interleukin 1 
(n^-l) produced by monocytes and macrophages stimulates acute-phase protein 
synthesis and promotes T-cell proliferation; it is also an endogenous fever-producing 
substance. Interleukin 6 (IL-6) secreted by many cells including T cells. It induces 
acute-phase protein synthesis and promotes T-cell activation and interleukin 2 (IL-2) 
production. It stimulates B cells to secrete immunoglobulins and serves as a colony 
stimulatory factor. IL-6 also stimulates hematopoietic progenitor cell growth. TNFa 
is made primarily by monocytes and TNPP is made primarily by T cells. TNFa and 
TNFP activate many different cells of both immune and nonimmune systems; both 
are cytotoxic to some tumor cells in vitro (Benjamini and Leskowitz, 1991). 
A fungal immunomodulatory protein (FIP-/ve) with hemogglutinating activity 
from the edible mushroom Ffammulina velntipes is found to enhance the 
transcriptional expression of IL-2 and interferon-y. The induction of cytokine gene 
expression by YW-pe is demonstrated by using murine spleen cells. The gene 
expression of IL-2 and interferon-y is examined by amplification of the cytokine 
transcripts by RT-PCR. The increased sensitivity of detection of transcripts by RT-
PCR reveals that VW-pe significantly induces IL-2 and interferon-丫 gene expression 
(Ko et al., 1995). IL-2 is a factor required for the growth of some T cells and for B-
cell activation to secrete immunoglobulins. Interferon-y activates killer T cells, 
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natural killer fNK) cells, and macrophages (Golub and Green, 1991; Kilpatrick. 
1995). 
2.2. Mushroom Lectins and Polysaccharides 
2.2.1. General aspects of mushroom lectins and polysaccharides 
Mushrooms can be defined as "macrofungi with distinctive fruiting bodies 
which can be either epigeous or hypogeous and large enough to be seen with naked 
eye and to be picked by hand" (Chang and Miles, 1992). The perception of 
mushroom as a highly nutritional foodstufF is well-founded. Many kinds of 
mushrooms are not only edible, but also possess tonic and medicinal qualities. 
Extensive clinical studies, primarily in China and Japan, have clearly demonstrated 
that a number of species have medicinal and therapeutic value in the 
preventionAreatment of cancer, viral diseases, hypercholesterolemia, blood platelet 
aggregation, and hypertension (Breene, 1990; Jong et al., 1991). Most of the studies 
have focused on Lentiriula edodes, Plenrotus spp., Flcmwnilhia vehnipes, 
Schizophylhnv corwmme, Corio/us versicolor and Ganoderma spp. Some 
mushrooms which contain antitumor activity in their aqueous extracts are shown in 
Table 2.2. Many of the active substances which include polysaccharides, nucleic acid 
derivatives, lipids, peptides, proteins and glycoproteins, have been isolated and 
identified. Some of the mechanisms of activity have been elucidated (Hajto et al., 
1990; Hirotani and Furuya, 1990; Chihara, 1992; Kraus et al., 1992; Ochiai et al., 
1992; Liu et al., 1993a; Wang et al., l995a). 
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Several edible mushrooms have been reported to have hypotensive efFects, 
for instance Grifola frondosa, Lenthnis edodes, Gaiwderma lucidum (Breene, 
1990), Plevrotus sajor-cajn (Tam et al., 1986) and VoJvarieUa volvacea (Chiu et aI., 
1995). Feeding powdered Grifola frondosa to the spontaneously hypertensive rat 
resulted in a lowering ofblood pressure (Adachi et al., 1988). An aqueous extract of 
P. sajor-cajn exhibited a hypotensive efFect in rats and a typical dose of 25 mg/kg 
body weight decreased the MAP from 110 to 70 mmHg (Tam et al., 1986). 
2.2.2. Mushroom lectins 
Over 100 lectins have been isolated and purified from plants, animals and 
microorganisms. Among the nearly 60 lectins commercially available, only one is of 
fungal origin, that is from Agaricus hispon/s (Pemberton, 1994). Early studies on 
mushroom lectins involved agglutination tests with red blood cells of human origin, 
but recently mainly use erythrocytes from various mammalian species, particularly 
the rabbit. Systematic explorations covering more than 600 species reveal the 
presence of lectins in about 30% of the higher fungi studied in 1960s to 1970s 
(Guillot et al., 1983). Pemberton (1994) tested a total of 403 species of fungi from 
widespread locations for lectin activities with human and rabbit erythrocytes and 
found that about 50% contained agglutinins. Table 2.3 shows some properties of the 
mushroom lectins (Horejsi and Kocourek; 1978; Kawagishi et al., 1988; Kawagishi, 
1995). 
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2.2.2.1. Herichnii erinacenni lectin 
Hericium erinaceum lectin is a tetramer containing two different subunits 
and their molecular weight is 15 K and 16 K respectively. The molecular weight of 
the intact lectin is estimated to be 54 K by gel filtration. The value of the 
carbohydrate content is 1.5%. Amino acid analysis reveals a high content of glycine, 
glutamic acid or glutamine, serine, alanine and a low content of tyrosine, histidine 
and methionine. This lectin is quite stable between pH 5.0 and 10.5, and below 
70°C. The hemagglutinating activity of the lectin is not affected by demetalization 
with EDTA, and addition of CaCb, MgCb, ZnCb or MnCb to the demetalized lectin 
does not cause any change of the activity. It exhibits specificity towards sialic acids, 
especially N-glycolylneuraminic acid (Kawagishi et al., 1994). 
2.2.2.2. Lactarius deterrinws lectin 
The lectin is isolated from carpophores of the mushroom Lactarws 
deterrinms, a specific symbiont of the spruce, by a combination of affinity, 
hydroxylapatite, and gel-filtration chromatography. Its molecular weight, as 
determined by gel filtration, is about 37 K, and its structure is dimeric, with two 
identical subunits assembled by noncovalent bonds. It appears homogeneous on 
high-performance liquid chromatography gel filtration, but isoelectric focusing 
reveals microheterogeneity, with a main band in the pH zone near 6.5. Amino acid 
analysis shows that the lectin contains a large proportion of glycine and especially 
methionine. No carbohydrate is detected in the lectin. Hapten inhibition assay 
indicates that L detemmus lectin is most specific for P-D-galactosyl (l-3)-D-N-
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acetyl galactosamine residues. The lectin is formed in the />? v/7ro-cuItured mycelium. 
Anti-lectin antibodies by indirect immunofluorescence reveals the presence of this 
lectin in the cell wall. Receptor sites for the lectin are found on the roots, especially 
on the root hairs, of axenically grown spruce seedlings. This suggests a role of the 
fungal lectin in recognition and specificity during the early stages of mycorrhizae 
formation (GiolIant et al., 1993). 
2.2.2.3. Lae1iponts sv1fiirevs lectin 
A hemagglutinating and hemolytic lectin has been isolated from carpophores 
of the parasitic mushroom Laeliporus sn/fnreus by affinity chromatography on 
Sepharose. Its molecular weight, as determined both by gel filtration and by 
electrophoresis in non-denaturing conditions, is about 190,000 and its structure is 
tetrameric, with two distinct types of subunits (about 60,000 and 36,000). The 
amino acid analysis shows that the most abundant amino acids are threonine, valine, 
and glycine whereas aspartic acid and sulfur amino acid are present in very small 
amounts. No carbohydrate is detected in the lectin. It appears homogeneous on 
HPLC gel filtration but exhibits microheterogeneity on isoelectric focusing. Hapten 
inhibition assay indicates that the L sidfnreus lectin is specific for N-
acetyllactosamine residues and that hemagglutinating and hemolysis activities are 
supported by the same site (Konska et al., 1994). 
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2.2.2.4. GrifoJa frondosa lectin 
An N-acetylgalactosamine-specific lectin is isolated from Grifola frondosa 
fruiting bodies by affinity chromatography on acid-treated Sepharose CL-4B and 
then GalNAc-Totopearl (Kawagishi et al., 1990). Molecular weight estimated by gel 
filtration under various buffers and matrices varies from 30 to 52 K. On the other 
hand, SDS-PAGE in the presence or absence of 2-mercaptoethanol shows three 
major bands of 33，66 and 100 K and a faint band of 65 K. This lectin exhibits 
GalNAc-specificity. The hemagglutinating activity of the lectin is not affected by 
demetalization and addition of CaCl2, MgCl2, ZnCl2 or MnCl2 to the demetalized 
lectin does not cause any change of the activity. G. frondosa lectin is a glycoprotein 
containing 3.3% sugar, and its amino acid analysis reveals a high content of acidic 
and hydroxyl amino acids, glycine and alanine, and a low content of methionine, 
phenylalanine, isoleucine and histidine. It is cytotoxic against HeLa cells. The 
minimum concentration giving complete death of the cells for the lectin is 25 ^ig/rnl 
and the toxicity does not appear after preincubating the lectin with the haptenic 
sugar N-acetylgalactosamine (Kawagishi, 1995). 
2.2.2.5. Volvariella volvacea lectin 
Volvariella volvacea lectin is isolated and purified from the fruiting body by 
extraction with 5% cold acetic acid in the presence of 0.1% 2-mercaptoethanol, 
followed by ammonium sulfate fractionation, and DEAE-C-52 column 
chromatographies (Lin and Chou, 1984). The molecular weight was determined to 
be 26,000, and the lectin consists of two non-identical subunits as demonstrated by 
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gel filtration and polyacrylamide gel electrophoresis. The lectin does not contain 
half-cystine, methionine, or histidine and the most abundant amino acids are aspartic 
acid, glutamic acid, tyrosine and leucine. Its hemagglutinating activity is stable at 
80°C (2 h incubation). However, 25% of the activity is lost when the lectin is treated 
at 90°C for 30 min. The hemagglutinating activity of the lectin is not inhibited by any 
of the common simple sugars. It is likely that the lectin has affinity for a complex 
carbohydrate structure on the cell surface. The V. volvacea lectin is toxic and the 
LD50 of the lectin is 17.5 mg per kg body weight of mice. The lectin has a moderate 
inhibitory effect on the growth of tumor cells. The life span of the control group, 
after inoculation of Sarcoma 180 cells by injection of 0.2 ml of ascitic fluid 
containing 2 x 10^ cells/mouse, was 12.5±5 days. The tested group given 85 |ig of 
the lectin by intraperitoneal injection showed a 63.2% increase oflife span, while the 
group given 175 i^g of the lectin showed a l09.7% increase. 
2.2.2.6. Flammulina veltipes lectin 
Flamnrulitia velutipes lectin was extracted from the fruiting body with 
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phosphate buffer and purified by zinc acetate treatment and CM-ceIlulose column 
chromatography (Tsuda, 1979). Its molecular weight is estimated to be 20,000 by 
gel filtration and polyacrylamide gel electrophoresis. The lectin does not contain 
carbohydrate, half-cystine, methionine, or histidine. On gel filtration with Sepharose 
6B in the presence of 6 M guanidine-HCl, the purified lectin dissociated into two 
nonidentical subunits, FVA-L (MW 12,000) and FVA-S (MW 8,000). The 
hemagglutinating activity is retained only in the FVA-L subunit and not inhibited by 
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any of the common simple sugars. Thus the F. velulipes lectin seems to have affinity 
for more complex carbohydrate structure on the cell surface. The lectin stimulates 
the proliferation of mouse splenocytes and only the large subunit, FVA-L, shows the 
mitogenic activity. 
Recently, a new fungal immunomodulatory protein, designated as YlV-Jve, 
has been isolated and purified from this edible mushroom (Ko et aI., 1995). It is 
extracted with ice-cold 5% acetic acid in the presence of 0.05 M 2-mercaptoethanol 
from the homogenized fruit body. The molecular weight of YW-pe determined by 
SDS-PAGE agrees well with the value of 12,704 calculated from its amino acid 
composition and sequence. The complete amino acid sequence of YlV-pe is 
elucidated by protein sequencing techniques. FIP-/vc? consists of 114 amino acid 
residues with an acetylated amino end, and lacks methionine, half-cystine and 
histidine residues. Staining of the SDS-PAGE gel with periodic acid-Schiffs reagent 
reveals negative staining, indicating that FIP-/ve is a simple protein. In the presence 
of 0.1 M D-glucose, D-galactose, D-fucose, N-acetyl-D-gIucosamine, N-acetyl-D-
galactosamine or lactose, no inhibition of hemagglutination is observed. The 
immunomodulatory activity of YW-pe is demonstrated by its stimulatory activity 
toward human peripheral blood lymphocytes, and its suppression of systemic 
anaphylaxis reactions and local swelling of mouse footpads. YW-pe is found to 
enhance the transcriptional expression ofinterleukin 2 and interferon-y. 
Many characteristics indicate that the FIP-/v^ may be FVA-L. Their 
molecular weights are similar, and their hemagglutinating activities are not inhibited 
by the common simple sugars. The amino acid contents of both YW-pe and FVA 
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(FVA-L and FVA-S) are similar, especially in the fact that both of them lack haIf-
cystine, methionine，and histidine residues (Tsuda, 1979; Ko et al., 1995). Because 
TW-pe is extracted with cold acetic acid in the presence of 0.05 M 2-
mercaptoethanol, another subunit, ifFVA-S exists, will separate from VW-pe. 
2.2.2.7. Ischnoderma resuiosvm agglutinin 
Ischrioderma resinosum agglutinin is purified from the fruiting body by 
affinity chromatography on Sepharose 4B (Kawagishi, 1995). The lectin is 
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composed of two identical subunits with a molecular weight of 16,000. Amino acid 
analysis reveals a high content of acidic and hydroxy amino acids, glycine, valine and 
leucine, and a low content of methionine, histidine and arginine. The carbohydrate 
content amounts to 4%. Among monosaccharides, methyl P-galactoside is the most 
potent inhibitor. Fucose and L-arabinose are also inhibitory (Kawagishi and Mizuno, 
1988). 
2.2.2.8. Lectins from Agaricvs spp. 
A. hlazei lectin is isolated and purified from the fresh fruiting body 
(Kawagishi et al., 1988). Its molecular weight, estimated by gel filtration on 
Toyopearl HW-555 is 64,000. It consists of four identical subunits each of which 
possesses a molecular weight of 16,000. Amino acid analysis reveals a high content 
of acidic and hydroxyl amino acids and glycine, and a low content of suIfur-
containing and aromatic amino acids. The value for carbohydrate content is 11%. 
The lectin is completely stable at temperature below 65°C. The hemagglutination 
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activity of the lectin is not inhibited by any of the common simple sugar tested. 
However, N-acetyl-D-galactosamine (2-acetamido-2-deoxy-D-galactose) and its 
methyl a-glycoside inhibit the hemagglutination at high concentrations (100-200 
mM). 
Two lectins from the mushroom A. edidis have been isolated and purified by 
ion exchange chromatography and gel filtration (Eifler and Ziska, 1980). The 
molecular weight of two lectins, designated lectin 1 and lectin 2，is 60,000 and 
32,000 and their carbohydrate content is 18% and 2% respectively. Neither cysteine 
nor cystine is found in either of the lectins. Lectin 1 consists of 4 subunits and lectin 
2 o f 2 subunits. The activity oflectins 1 and 2 is unaffected by heating for 10 min at 
75°C and 85°C respectively. Also, incubation of the lectins in 6 M urea at room 
temperature for 60 min and in buffers with pH from 2-11 have no influence on their 
hemagglutinating activity. The hemagglutination oflectin 2 is not inhibited by any of 
the common simple sugars (Kawagishi et al., 1988). 
A lectin has been isolated from the fresh mushroom A. campestris (Sage and 
Vazquez, 1967). It is a tetramer and the intact molecular weight is 64,000. Its 
hemagglutination activity is stable at the temperature range of 0-80°C and the pH 
range of 4-10. The carbohydrate content of the lectin is 4%. The hemagglutinating 
activity is not inhibited by any simple sugars tested. Amino acid analysis shows a low 
content of half-cystine, methionine, histidine, proline, and tryptophan, and a high 
content of aspartic acid, threonine or glutamic acid (Sage and Connett, 1969). 
Two lectins with similar specificities for cell surface carbohydrate receptors 
have been partially purified from the commercial mushroom Agaricvs hisponis 
32 
^*resant and Kornfeld, 1972; Kawagishi et al., 1988). Four lectins have also been 
purified from this mushroom by Sueyoshi et al. (1985). Polyacrylamide gel 
electrophoresis of each lectin in the presence of sodium dodecyl sulfate gives a single 
band with an apparent molecular weight of 16,000. Sedimentation equilibrium 
analysis suggests that each lectin is a tetramer. The four lectins are found to have 
quite similar carbohydrate-binding specificities (Sueyoshi et al., 1988). 
Among the nearly 60 lectins commercially available (by Sigma Chemical 
Company, USA), A. bisponis lectin (ABL) is the only one of mushroom origin. ABL 
is a mixture of two lectins with similar specificities for carbohydrate receptors 
according to the report of Presant and Kornfeld (1972). It has been studied on its 
reversible inhibition of proliferation of epithelial cell lines. It produces a marked 
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inhibition of thymidine incorporation in a dose-dependent manner in human colon 
cancer cell HT29 and Caco-2, breast cancer cells MCF-7, and rat mammary 
fibroblasts Rama-27. The rate of inhibition of thymidine incorporation at the dose of 
25 ^g/ml of the lectin is 87%, 16%, 50% and 55% for HT29, Caco-2, MCF-7 and 
Rama-27 cells respectively when these cells are grown for 24 h in serum-free 
medium. When assessed by cell count, a similar inhibition of proliferation of HT29 
cells is found. In the presence of 2% fetal calf serum (which contains the A. bisporus 
lectin-binding glycoprotein fetuin), the inhibition effect of the lectin on cell 
proliferation is still demonstrable at an increased concentration (60 ^g/ml for 49% 
inhibition). Ten ^ig/ml of the lectin completely abolishes the stimulatory effect on ^H-
thymidine incorporation of epithelial growth factor (100 pgAnl) and markedly 
inhibits the stimulatory effect of insulin (50 ng/ml). A. bisporus lectin (0.2 mgAnl) 
33 
causes no cytotoxicity to HT29, MCF-7, and Rama-27 cells as measured by trypan 
blue exclusion, and inhibition of proliferation in HT29 cells caused by 50 ^ig/ml is 
reversible after removal of the lectin. The mechanism of the lack of cytotoxicity of 
the lectin is not clear. A. bisporus lectin is a reversible noncytotoxic inhibitor of 
epithelial cell proliferation which deserves study as a potential agent for cancer 
therapy (Yu et al., 1993). 
2.2.3. Mushroom polysaccharides 
Some antitumor polysaccharides or polysaccharide-peptide complexes 
isolated from fungi (fruiting body, mycelium or culture medium) are shown in Table 
2.4 with their chemical structures (Mizuno et al., 1995a). The antitumor 
polysaccharides, in most cases, are glucans with different types of glucosidic 
linkages. Some structural features are obvious prerequisites, i.e. P-l,3-linkage in the 
main chain of the glucan and further P-l,6-branch points. The mechanism of action 
of these polysaccharides or polysaccharide-peptide complexes has not been 
completely elucidated, but it has been suggested that the action is host-mediated and 
not directly cytocidal (Breene, 1990). It has been reported that fungal 
polysaccharides and polysaccharide-peptide complexes such as lentinan (Maeda and 
Chihara 1971; Mizuno et al., 1995b), PSK (Tsukagoshi et al., 1984), schizophyllan 
(Jong et al., 1991; Ohno et al., 1995), and polysaccharopeptide (PSP) (Yang et al., 
1992) are effective growth inhibitors of Sarcoma 180 implanted in mice. The 
antitumor activities are attributed to stimulation of the cell-mediated immune 
response. Activated macrophages, natural killer cells, cytotoxic T cells and their 
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secretory products, such as tumor necrosis factor, reactive nitrogen and oxygen 
intermediates, and interleukins have been reported to be involved in the 
immunomodulatory responses (Jong et al., 1991; Liu et al., 1993a). 
2.2.3.1. Lentinan 
Lentinan is isolated and purified from the fruiting body of Lentimis edodes 
(Chihara et al., 1969). It exerts antitumor activity in murine allogeneic, syngeneic, 
and autochthonous hosts, prevents chemical and viral oncogenesis, and suppresses 
tumor metastases in several clinical models (Chihara, 1992). It is also able to 
increase host resistance against various bacterial, parasitic, and viral infections 
(Mizuno et al., 1995b). Lentinan appears to act as a host defence potentiator, an 
agent which restores or augments host-cell responsiveness to lymphokines, 
hormones, and other bioactive factors by stimulating maturation, differentiation, and 
proliferation of crucial cells in host defense mechanisms and by improving host 
homeostasis. Lentinan exhibits only mild toxic side effects in animal and human 
models. There is evidence that lentinan applied in combination with chemotherapy 
increases 50% survival when compared to chemotherapy alone (Maeda and Chihara, 
1971; Ochiai et al., 1992). 
2.2.3.2. PSK (trade name, Krestin) 
PSK is a protein-bound polysaccharide, extracted by hot water from the 
mycelia of Coriolns versicolor (Tsukagoshi et al., 1984). It is a brownish powder 
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and the protein content is 38%. The main component of the carbohydrate moiety is 
glucose, with galactose, mannose, xylose and fucose as minor components. The 
protein moiety is rich in acidic amino acids (such as aspartic acid, glutamic acid) and 
neutral amino acids (such as valine and leucine), with basic amino acids (such as 
lysine, arginine) in small amounts. PSK is highly soluble in water but only slightly 
soluble in most organic solvents (methanol, pyridine, chloroform, benzene or 
hexane). It has been shown to contain at least four different subfractions which are 
separable by stepwise filtration through a membrane filter or by isoelectric 
precipitation. PSK has been reported to induce host-mediated antitumor activity 
(Sakagami et al., 1991). Clinical application of PSK to cancer patients is only 
permitted in combination with other chemotherapeutic agents. Moreover, PSK 
induces potent antimicrobial activity in ICR mice. It stimulates the production of 
tumor necrosis factor and interleukin 1 by human peripheral blood mononuclear cells 
and potentiates the actions of some cytokines such as tumor necrosis factor and 
interferon-y (Kim et al., 1990; Tsuru et al., 1991). 
PSK can be separated into four subfractions with different molecular weights 
by successive filtration through membrane filters: F1 (<50 K), F2 (50-100 K), F3 
(100-200 K) and F4 (>200K), with relative yields of 1:1:10:10. The highest 
molecular weight fraction (F4) among these fractions shows the greatest 
immunomodulatory and antitumor activities (Sakagami et al., 1991). 
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2.2.3.3. PSP (Polysaccharopeptide) 
A polysaccharide-peptide complex with antitumor activity which is different 
from PSK has been obtained by extraction of the mycelia of Coriolus versicolor 
(Yang et al., 1992). The results carried out in China show that PSP does not exert 
any cytotoxicity on cultured mouse peritoneal macrophages and five tumor cell lines, 
including two macrophage-like cells (PU5-1.8 and P388D1), human 
choriocarcinoma cell line (JAR), mouse melanoma cell line (B16) and mouse 
sarcoma cell line (S180). It could hardly stimulate the production of reactive 
nitrogen and oxygen intermediates and TNF by macrophages in the culture. 
However, when the mice are pretreated with PSP, the production of these molecules 
by macrophages is greatly enhanced, indicating that PSP is an immunomodulatory 
rather than a direct cytotoxic substance on the tumor cells tested in the study (Liu et 
al., 1993a). The antitumor effect of a small polypeptide from PSP is also reported by 
Yang et al. (l992m). 
Studies have shown that nitric oxide is probably one of the most important 
messenger molecules. It enables macrophages to kill tumor cells by inhibiting the 
energy-producing Krebs cycle and electron transport system as well as DNA 
synthesis. Nitric oxide is extremely labile and is short-lived (Fukuto, 1995). It is 
formed by activated macrophages in the course of oxidation ofL-arginine to nitrates 
(NO3-), nitrites (NO2") and citrulline. Nitric oxide exists for about six to ten seconds 
and then is converted by oxygen and water into nitrates and nitrites. In many studies, 
nitrite ion is determined instead of nitric oxide. The endothelium-derived nitric oxide 
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allows neurotransmitters to dilate blood vessels (Keller and Keist, 1989; Andrews et 
al., 1990; Keller et al., 1990; Snyder, 1992). 
2.2.3.4. PSPC (polysaccharide-peptide complex) 
Recently, a polysaccharide-peptide complex with immunomodulatory and 
antitumor activities has been isolated from a submerged mycelial culture of 
Tricholoma sp., a local edible mushroom in Hong Kong. The polysaccharide-peptide 
complex has a molecular weight of 17 K in gel filtration and a single band after SDS-
polyacrylamide gel electrophoresis. It is characterized by non-adsorption on both 
DEAE-Sepharose CL-6B and CM-cellulose. It could activate macrophages, 
stimulate the proliferation ofT-cells, and inhibit the growth of Sarcoma 180 in mice. 
It exhibits more potent immunomodulatory and antitumor activities than Coriolus 
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versicolor polysaccharopeptide (PSP) (Wang et al., 1995a). Another antitumor 
component is found in the culture filtrates of Tricholoma lohayense in the same 
laboratory. It behaves as a protein-bound polysaccharide with a molecular weight of 
154 K when estimated by gel filtration. It can inhibit the growth of Sarcoma 180 
cells which were implanted in mice by intraperitoneal or subcutaneous injection (Liu 
et al., 1995). This protein-bound polysaccharide possesses the ability to restore the 
phagocytic function of peritoneal exudate cells and mitogenic the activity of T-cells 
of the tumor-bearing mice (Liu et al., 1996b). It is also able to induce gene 
expression of some immunomodulating cytokines in mice (Liu et al., 1996a). 
38 
Table 2.1. Chemical properties of several highly purified lectins 
Source Molecular Sub- Sugar Inhibitory 
weight units (%) sugars� 
Arachis hypogaea 106,000 4 <0.3~~~D-Gal 
Canavalia emiformis (Con A) 55,000 2 0 a-D-Man 
Dolichos hif!orns (DBA) 140,000 4 3.8 a-D-GalNAc 
Glycim max (SBA) 110,000 4 5 D-GalNAc 
Helix pomatia 100,000 6 7.3 a-D-GalNAc 
Lens culinaris 49,000 2 3 a-D-Man 
Lotus tetragofiolohus (Lotus A) 120,000 4 9.4 a-L-Fuc 
(Lotus B) 58,000 2 4.8 a-L-Fuc 
(Lotus C) 117,000 4 9.2 a-L-Fuc 
Momordica charatitia 124,000 3^  5 D-Gal 
Thchosanthes kihlowii (TK-I) 55,000� 2' 1.5 D-Gal 
(TK-II) 58,000' 2^  2.7 D-Gal 
(TK-III) 66,000' 2 3.7 D-Gal 
Tritiawi vulgaris (WGA) 36,000 2 4.5 (D-GlcNAc)2 
Vicia faha 50,000 4^ < 1 D-Man, D-Glc 
.Visciim alhimi (ML I) 115,000 2^  11 D-Gal 
a The molecular weight was determined by SDS-polyacrylamide gel electrophoresis, 
b Subunits are of different molecular weights. 
c Abbreviations: D-Glc, D-glucose; D-Gal, D-galactose; D-Man, D-mannose; D-
GalNAc, N-acetyl-D-galactosamine; (D-GlcNAc)2, di-N-acetylchitobiose; L-Fuc, L-
fucose. 
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Table 2.2. Screening of water extracts of some mushrooms for antitumor activity 
against Sarcoma 180 (Mizuno et al., 1995) 
No. Mushroom Tumor inhibition Complete 
Q ^ regression 
A. Polyporaceae 
1 Coriolus hirsvtus 65.0 2/10* 
2 Coriolus puhesscem 59.5 0/10 
3 Coriolus versicolor 77.5 4/8 
4 Daedaleopsis cytisina 70.2 4/7 
5 Favolus a/veolarius 71.9 0/10 
6 Fomitjpsis cytisina 44.2 3/10 
7 Foniitopsis piriicola 51.2 3/9 
8 Ganoderma applajiatum 64.9 5/10 
9 Ganoderma tsiigae 77.8 2/10 
10 Hirschioporus fnsco vioIaceiis 4 5.5 1 /10 
11 Lenzites hetvline 23.9 0/8 
12 Levcofomes ulmarius 44.8 0/7 
13 Piptoporus helulimis 49.2 0/7 
14 Tramctes dickinsii 80.1 0/8 
15 Trametes gihhosa 49.2 1/10 
B. Mucronoporaceae 
16 Phellinus hartigii 67.9 1/9 
17 Phelli7ms igfiiaarius 87.4 6/9 
18 PheHhms Untens 96.7 7/8 
C. Tricholomataceae 
19 Flammulina velutipes 81.1 3/10 
20 Leritinus edodes 80.7 6/10 
21 Pleurolus ostreatus 75.3 5/10 
22 Pleurotiis spodoJencus 72.3 0/8 
23 Tricholoma matsntake 91.8 5/9 
D. Strophariaceae 
24 Pholiota riameko 86.5 3/10 
E. Auriculariaceae 
25 Auna/lana amiculajudae 42.6 0 ^ 
* 2 out of 10 mice showing complete regression. 
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Table 2.3. Lectins isolated from mushrooms 
Source Molecular Sub- Sugar (%) Inhibitory Refe-
weight units sugars^ rence^ 
Agaricm bisporm 64,000 4 1.8-6.4 Galpl-3 1,2, 3 
GalNAc 
Agaricus hlazei 64,000 4 11 4 
Agaricus campestris 64,000 4 4 5, 6 
Agahcm edulis (I) 60,000 4 18 4,7 
(II) 32,000 2 2 
Agrocybe aegerita 44,000 2 Gal 8 
Aleuria aurantia 72,000 2 0 L-Fuc 9, 10, 11 
Anriculariapolylricha 23,000 1 3.5 Lac, Gal 12 
Clitocyhe nehuIaris 70,000 4-5 2.6 Lac, GalNAc 13, 14 
F/ammnlina velutipes 20,000 2 0 15 
Flamnwlina velntipes 12,704 1 0 16 
(FIP->e) 
Fonies fomentarws 60,000 3 25 GalNAc, Raf 13 
Grifolafrondosa >100,000 >3 3.3 GalNAc 17 
Hericium eriiiaceum 54,000 4 1.5 NGNA 18 
lschnoderma resinosum 32,000 2 4 Lac, Gal 19 
Laccaria amethystina I 17,500 1 Lac, GalNAc; 20 
II 16,000 1 L-Fuc 
Lactarim deterrinws 37,000 2 0 D-Gaipi-3D- 21 
GalNAc 
Lactarius lignyotus 100,000 4 4 22 
Laetiporns suJfitreus 190,000 4 0 D-LacNAc 23 
Marasmiiis oreades 50,000 2 5.4 13,14 
Phallus impvdicm 75,000 4 13.9 24 
Psathyrella velutina 40,000 1 0.5-0.7 GlcNAc 25 
Volvahella volvacea 26,000 2 26 
Xerocomns chysenteron 17,000 1 ^ ^ 
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® Abbreviations: Lac, lactose; Raf, raffinose; D-Gaip 1 -3D-GalNAc, P-D-galactosyl( 1 -3)-
D-N-acetylgalactosainine; NGNA, N-glycolylneuraminic acid; D-LacNAc, N-acetyl-D-
lactosamine; other abbreviations as in Table 1. 
I ‘ 
The reference numbers indicates: (1) Presant and Kornfeld, 1972; (2) Sueyoshi et al., 
1985; (3) Sueyoshi et al., 1988; (4) Kawagishi et al, 1988; (5) Sage and Vazquez, 1967; 
(6) Sage and Connett, 1969; (7) Eifler and Ziska, 1980; (8) Ticha et al.，1985; (9) 
Kochibe and Fuaikawa, 1980; (10) Yamashita et al., 1985; (11) Debray and MontreuiI, 
1989; (12) Fumio and Kenjiro, 1988; (13) Horejsi and Kocourek, 1978; (14) Kawagishi, 
1995;(15)Tsuda, 1979;(16) Ko etal., 1995;(J7) Kawagishi et al., ]990; (18)Kawagishi 
et al., 1994; (19) Kawagishi and Mizuno, 1988; (20) Guillot et al.，1983; (21) Giollant et 
al., 1993; (22) Sychrova et al., 1985; (23) Konska et al., 1994; (24) Entlicher et al., 1985; 




Table 2.4. Polysaccharides with antitumor activity isolated from mushroom fruiting 
bodies, mycelia and culture media 
Mushroom Fruiting body Mycelium Me^um 
Auriadaria P_Glucan - ‘ -
auriculajndae 
Cordyceps . , - - 6-Glucan 
ophiogl6ssoiaes 
Coriolus versicolor P-Glucan pr^t§n^f^§k) “ 
CrepidotKs mollis P-GIucan - -
Flanmrulifia veh(tipes P-Glucan-protein Glycoprotein -
• 
Fomitipsis pinicola p-Glucan - -
Garioderma applanati(m P-Glucan P-Glucan -
Ganoderma lncidi(ni P-Glucan - p-Glucan 
Hetero-P-glucan 
Grifola frondosa P-Glucan (Grifolan) - -
Acidic P-glucan 
Hetero-P-glucan 
Grifola nmbellata P-GIucan - -
Lentimis edodes P-Glucan (Lentinan) a-Mannan- Heteroglu-can-
peptide proiein 
Lenzites beUtlina p-Glucan - -
Ompha/ina epichysinm P-Glucan - -
Pholiota nanieko Galacto-P-glucan - -
Plev_is ostreatm P-Glucan - -
Poria cocos P-Glucan - -
Psevdopletania nigrella - - p-Glucan 
Schizophyliim commum - - p-Glucan 
(Shizophyllan) 
Scleritinm glucanicum p-Glucan - P-Glucan 
Sclerotiriia lihertirian P-Glucan - -
Volvariella volvacea P-Glucan - -
q-manno-3-glucan 
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C H A P T E R 3 
Isolation and Characterization ofTwo Distinct Lectins from the 
Cultured Mycelium of the Edible Mushroom Tricholoma mon^oHcnm 
3.1. Introduction 
Lectins are proteins or glycoproteins with specific binding sites for sugars 
which are not antibodies or enzymes (Franz, 1986). They have become useful tools 
for the structural studies of the cell surface,, oligosaccharides and/or carbohydrate 
moieties of glycoproteins (Sharon and Lis, 1972; Konska et al., 1994). Some lectins 
have been shown to have antitumor and immunomodulatory activities (Lin et al., 
1970; Lin and Chou, 1984; Hajto et al., 1990; Kawagishi et al., 1990; Beuth et al., 
1991, 1992; Yu et al., 1993; Ganguly and Das, 1994; Ko et al., 1995). 
Many lectins have been isolated from fungi, principally from edible species 
which are readily available: Agaricus bisponis�A. campestris, A. edn/is, Agrocyhe 
aegerita, Pha//iis impiidicns, A/cnria anraiitia (Kawagishi et al., 1988; Pemberton, 
蠢 
1994), Hericiinv erinacenm (Kawagishi et al., 1994), Laetiporns siilf)ireus (Konska 
4 4 
''6 
et al., 1994) and Flamnndina veIutipes (Ko et al., 1995). The observations on lectins 
specific for tumor cells have led to a great surge of interest in these compounds, 
especially among scientists engaged in cancer research. Some lectins preferentially 
agglutinate mammalian cells that have been transformed by oncogenic viruses or by 
chemical carcinogens, as well as spontaneously transformed cells. These and related 
findings indicate that studies with lectins may lead to a better understanding of 
cancer. Moreover, some lectins may be used to inhibit the growth of malignant cells 
(Sharon and Lis, 1972). 
The isolation and characterization of two lectins from the cultured mycelium 
of Tricholoma mongoliatm, an edible mushroom is reported herein. 
3.2. Materials and Methods 
3.2.1. Strain and culture condition 
The strain of T. wongoUami was collected and isolated in Hebei Province, 
China. The culture medium used for the strain was made up by dissolving 24 g 
potato dextrose broth, 5 g peptone, 0.46 g KH2PO4, 1 g K2HPO4, 0.5 g 
MgSO4.7H2O and 20 mg vitamin Bi in one liter of distilled water. The pH of the 
medium was 6.0. The T. moiigolictmi mycelium was cultured at 25°C for 9 days in 







The culture broth was filtered through cheesecloth. The mycelium was 
washed free of culture broth with distilled water, homogenized in a blender, and then 
extracted overnight with cold saline at 4°C. The resulting suspension was 
centrifuged at 12,000 rpm for 20 min. The supernatant was fractionated with 30-
8 0 % saturated ammonium sulphate. The precipitate collected by centrifugation was 
dissolved in and dialyzed overnight against distilled water with three changes of 
water. Denatured protein was removed by centrifugation and the supernatant was 
lyophilized. The resulting powder was designated as crude powder (Yeung et al., 
1986; Dong et al., 1993，1994; Giollant et al., 1993). 
3.2.3. Purification 
The crude powder from T. mongolicum was redissolved in 5 mM ammonium 
bicarbonate buffer (pH 9.0) and applied to a DEAE-cellulose column (1.0 x 22 cm) 
which had been equilibrated with the buffer. After unadsorbed materials had been 
eluted with the buffer, adsorbed materials were eluted stepwise with 50 mM, 150 
niM and 1 M ammonium bicarbonate buffer (pH 9.0) using a flow rate of 20 ml/h. 
The fractions were lyophilized and designated as A, B, C, D and E respectively. 
Fraction D was applied to a Sephadex G-lOO column (1.0 x 75 cm) which was 
eluted with 50 mM ammonium bicarbonate buffer (pH 9.0) at a flow rate of 18 ml/h. 
Three fractions were obtained and designated as D 1 , D2 and D3 respectively. 
I 
Fraction D 2 was chromatographed with a GradiFrac system on an SP-Sepharose 
column (HiLoad 16/10). It was first eluted with 10 mM ammonium acetate buffer 
4 6 
(pH 5.5) and then with a linear gradient of 0-0.5 M sodium chloride in the buffer at a 
flow rate of 1.5 ml/min (Dong et al., 1993, 1994; Kawagishi et aI., 1994). The two 
resulting fractions were lyophilized and designated as T M L - 1 and T M L - 2 
respectively. 
3.2.4. Hemagglutination activity 
Hemagglutination tests were carried out at room temperature using a 2 % 
suspension of rabbit erythrocytes in pH 7.2 phosphate-buffered saline (PBS) and a 
serial two-fold dilution of the lectin solution in microtiter U-plates. Fifty microliters 
of each dilution were transferred to a well of a microtiter plate. A row of wells filled 
with a series of dilutions was thus obtained. All of the dilutions were mixed with 50 
^il of the 2 % rabbit erythrocyte suspension. The results were read after about 1 h 
when the blank had fully sedimented. The hemagglutination titer was defined as the 
reciprocal of the highest dilution exhibiting hemagglutination and was reckoned as 
one hemagglutination unit. Specific activity is the number of hemagglutination units 
per mg protein QSTg et al., 1986; Kawagishi et al., 1990). 
3.2.5. Test ofhemagglutination inhibition by various carbohydrates 
The hemagglutination inhibition tests were performed in a manner analogous 
to the hemagglutination test. Serial twofold dilutions of sugar samples were prepared 
in PBS bufFer. All of the dilutions were mixed with an equal volume (25 ^il) of a 
i 
solution of the lectin with 3 hemagglutinating units. The mixture was allowed to 





erythrocyte suspension. The minimum concentration of the sugar in the final reaction 
mixture which completely inhibited 3 hemagglutinating units of the lectin preparation 
was calculated (Horejsi and Kocourek, 1978; Giollant et al.，1993; Konska et al.， 
1994). • 
3.2.6. Molecular weight (MW) estimation by gel filtration and sodium dodecyl 
sulfate-poIyacrylamide gel electrophoresis (SDS-PAGE) 
Gel filtration o f T M L - l and T M L - 2 was performed with a GradiFrac system 
on a Superdex 75 column (HiLoad 16/60). The column was eluted with 0.1 M NaCl 
in 0.01 M Tris-HCl buffer (pH 7.5) at a flow rate of 0.8 ml/min. Standard protein 
markers used included cytochrome C (MW 12,400), chrymotrypsinogen A (MW 
25,000), ovalbumin (MW 43,000), and bovine serum albumin (MW 67,000). Blue 
dextran was used for determination of the void volume of the column (Giollant et al.， 
1993;Dong et al., 1994). 
S D S - P A G E was carried out in 1 0 % gel at pH 8.9. Prior to electrophoresis, 
the samples were boiled for 5 min with 2 % SDS in the presence of 2 % 2 -
mercaptoethanol. After electrophoresis the gels were stained for 30 minutes with 
Coomassie brilliant blue R-250. The molecular weight standards (Pharmacia, 
Sweden) used included phosphorylase b (MW 94,000), bovine serum albumin (MW 
67,000), ovalbumin (MW 43,000), carbonic anhydrase (MW 30,000), soybean 
i 
trypsin inhibitor (MW 20,100) and a-lactalbumin (MW 14,400). The molecular i 




electrophoretic mobilities with those of standard molecular weight marker proteins 
(Kawagishi et al., 1990，1994). 
3.2.7. Glycoprotein staining with periodic acid-Schiff (PAS) reagent 
The presence of carbohydrates in the lectins was tested by PAS staining after 
electrophoresis in polyacrylamide slab gel containing 0 . 1 % SDS. The gels were 
incubated for 50 minutes in Schiffs reagent at 4 ° C in the dark and then washed 3 
times in freshly prepared 0 . 5 % sodium metabisulfite (Dong et al., 1994). 
3.2.8. Carbohydrate content 
The anthrone method was used to determine the carbohydrate contents of 
T M L - 1 and T M L - 2 which were expressed in glucose equivalents (Kawagishi et aI., 
1990). 
3.2.9. Thermal stability 
The lectin solutions were preincubated for 30 min at each of the following 
temperatures: 10°C, 20°C, 30°C, 40°C, 50°C, 60°C, 70°C, 80°C, 90°C or 100°C in 
a water bath. The hemagglutination activity of the heat-treated lectins was 
determined as described above (Kawagishi et al., 1994). 
3.2.10. pH stability 
The two lectins were preincubated in 0.025 N, 0.05 N and 0.1 N HC1 or 
NaOH. After 24 h an equal volume of N a O H or HC1 was added to achieve 
49 I 
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neutralization. The hemagglutination activity of the acid- or alkali-treated lectins was 
determined. The controls were treated with PBS buffer (pH 7.2) (Dong et al., 1993; 
Kawagishi et al., 1990，1994). 
3.2.11 . Effect of cations 
To examine the cationic requirements of hemagglutination induced by the 
lectin, the lectin sample was demetalized by dialysis exhaustively against 10 mM 
E D T A and the hemagglutination activity of the demetalized lectin was determined. 
The treated lectin was then incubated with one of the following cations: 1 mM 
CaCl2, MgCl2, ZnCl2 or MnCl2 in PBS (pH 7.2) for 2 h, and their hemagglutination 
activities were determined (Kawagishi et al., 1994). 
3.2.12. Amino acid analysis 
After hydrolysis ofthe lectin samples in 6 N HC1 at 1 1 0 � C for 24 h in sealed 
evacuated tubes, amino acids in the hydrolyzate were analyzed with an automatic 
amino acid analyzer (Beckman 6300) (Dong et al., 1994; Kawagishi et al., 1994). 
Hydroxyproline was determined by the method of Switzer and Summer (1971). 
3.2.13. Antiproliferative activity of lectins 
Tumor cell lines including PU5-1.8 (mouse monocyte-macrophage), P815 
(mouse mastocytoma), P388D1 (mouse monocyte-macrophage) and S-180 (mouse 
sarcoma) were cultured at the density of 1 x 10^ cells/0.2 ml/well in the presence of 
a serial two-fold dilution of lectin (40，20, 10 and 5 |ig/ml) and different 
I 
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concentrations of fetal bovine serum (0, 2.5, 5 and 10%) for 48 h before they were 
pulsed with 0.5 piCi/10 ^il/well of ^H-thymidine (Amersham, England) for 6 h. The 
uptake of the radioisotope by the cells was measured with a liquid scintillation 
counter and the antiproliferative activity indices of the lectins were calculated as 
follows (Hajto et al., 1990; Liu et al., 1993a; Yu et al., 1993; Ganguly and Das, 
1994): 
Antiproliferative activity index = (A - B)/A x 100 
where A = average counts per minute of control group and 
B = average counts per minute oflectin-treated group 
3.2.14. Statistics 
Data were analyzed using one-way analysis of variance and matched-pair 
comparisons were further made by Student's /-test ((one-tailed). The level of 
significance was taken at P < 0.05. 
3.3. Results 
3.3.1. Extraction and purification 
The photograph and drawing of the colony and the fruiting body respectively 
of T. motigolicum are shown in Figures 3.1 and 3.2. After anion-exchange 
chromatography of crude powder on DEAE-cellulose, five peaks were observed. 





D possessed the highest agglutinating activity on rabbit erythrocytes (Table 3.1). 
After gel filtration of fraction D on Sephadex G-100, three fractions designated D 1 , 
D 2 and D3 resulted (Fig. 3.4). Fraction D2 which contained mostly lectin was 
chromatographed on an SP-Sepharose column. Two lectins designated as T M L - 1 
and T M L - 2 were obtained (Fig. 3.5). The hemagglutinating activities of the two 
lectins against rabbit erythrocytes are shown in Table 3.1. The procedure of 
extraction and purification is shown in Figure 3.6. 
3.3.2. General characteristics oflectins 
The results of gel filtration on the Superdex 75 column (HiLoad 16/60) 
showed that both T M L - 1 and T M L - 2 possessed the molecular weight of 38,000 
(Fig. 3.7). After SDS-PAGE in the presence of 2-inercaptoethanol, both lectins were 
broken down into two subunits with the same molecular weight, 17,500 (Fig. 3.8-
3.9). Thus it appears that both lectins, T M L - 1 and TML-2, are dimeric, each 
consisting of two subunits. 
No pink band appeared after PAS staining, and so these two lectins may not 
contain any sugar. Carbohydrate was found in neither lectin when the anthrone 
method was used. The hemagglutinating activities of the two lectins were stable 
between 10°C and 80°C. However, at or above 90°C, all of the activity was 
destroyed. 
About 94% and 9 7 % respectively of the hemagglutination activities o f T M L - | 
1 and T M L - 2 were destroyed after treatment with HC1 at the concentrations of 
• 
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0.025 N and 0.05 N NaOH. The activity o f T M L - 1 was completely retained and that 
of T M L - 2 was partially (50%) destroyed after treatment with 0.025 N NaOH. 
However, in 0.1 N NaOH, all of the hemagglutination activities in the lectins was 
abolished (Table 3.2). 
The hemagglutination activities o f T M L - 1 and T M L - 2 were not affected by 
demetalization, nor after addition of 1 mM CaCb and MgCl2. However, when ZnCl2 
or MnCl2 was added, the hemagglutination activities of the two lectins decreased to 
1/4 of the original activities. 
The amino acid compositions of T. mo)igoliaim lectins are shown in Table 
3.3. They represent the means of data from two separate analyses which were in 
close agreement. Both lectins were characterized by a high content of Asx, Thr, Glx, 
Gly and Val and a low content of Arg and His residues. Prominent differences 
j between T M L - l and TML-2 resided in the content of Pro and Tyr residues. They 
had the same hydroxyproline content which was 3.5 ^g/mg protein. For comparison 
with the T. motigolicum lectins the amino acid compositions of five other mushroom 
lectins are also included (Table 3.3). It can be seen that the resemblance was the 
1 
closest between T M L - l and TML-2 althrough there was an overall similarity among 
i j 
the lectins. 
a-Lactose, P-lactose, lactose, N-acetyl-D-galactosamine and D-galactose 
were potent inhibitors of the hemagglutinating activities of T M L - 1 and TML-2 on | 
rabbit erythrocytes. The minimum concentrations of the various aforementioned 
sugars completely inhibiting 3 hemagglutinating units of the lectins were respectively 
25, 25, 25, 50 and 100 mM. Sugars showing no inhibition ofhemagglutination when 
| : ' i 
i 
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tested up to 200 mM included L-rhamnose, L-arabinose, D-arabinose, D-glucose, D -
mannose, D-xylose, D-fucose, D-fructose, L-fructose and N-acetylneuraminic acid. 
3.3.3. Antiproliferative activity oflectins 
Both T M L - 1 and T M L - 2 produced a marked dose-dependent inhibition of 
^H-thymidine incorporation in PU5-1.8 and P815 tumor cell lines. Figure 3.10 
shows the effects of the two lectins against P815 cells. At 5 jLigAnl, the 
antiproliferative activity indices of T M I - 1 and T M L - 2 in the absence of serum were 
respectively 5 2 . 7 % and 67.5%. The activities were markedly inhibited in the 
presence of 2 . 5 % serum (p < 0.05) and nearly completely suppressed when the 
concentration of serum was increased to 5 % and 1 0 % (Fig. 3.11). 
The antiproliferative activity of T M L - 1 against PU5-1.8 cells is shown in 
Figure 3.12. The activity was significantly suppressed by 2 . 5 % , 5 % and 1 0 % serum 
(p < 0.05). However, it is noteworthy that 52.4% of the activity of 40 ^ig/ml T M L - 1 
still remained in the presence of 1 0 % serum. 
Figure 3.13 shows the antiproliferative activity of T M L - 2 against PU5-1.8 
cells. Its activity was also markedly inhibited by the serum (p < 0.05). In the 
I , 
i. i： 
presence of 1 0 % serum, the antiproliferative activity of T M L - 2 was completely 
丨. 
abolished. 
The antiproliferative activity of the two lectins was not significantly different 
(p > 0.05) from the controls (culture free of lectin) when the P388D1 and S-180 
i'. 
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tumor cells were treated with either lectin at the concentration of 5-40 ng/ml in the 
presence of different concentrations of fetal bovine serum (Fig. 3.14-3.17). 
. ii 
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3.4. Discussion 
There are many reports which describe the isolation of lectins from 
mushrooms (Lin and Chou, 1984; Giollant et al., 1993; Kawagishi et al., 1994; 
Konska et al., 1994). However, the biological functions of most of the mushroom 
lectins are not known (Kawagishi et al., 1990). In the present study two lectins, 
designated as T M L - 1 and TML-2, were purified using ion exchange chromatography 
and gel filtration from the mycelium of T. mongoIicum, a famous edible mushroom 
isolated from Hebei Province in China. Their molecular weights were 38,000 when 
estimated by gel filtration. In SDS-PAGE, both lectins could be dissociated into two 
subunits with a molecular weight of 17,500. Thus T M L - 1 and TML-2 appeared to 
be dimeric and their molecular weights were about 37,000. The molecular weights of 
most lectins isolated from mushrooms were ranged from 32,000 to 64,000 (Horejsi 
and Kocourek, 1978; Lin and Chou, 1984; Kawagishi and Mizuno, 1988; Kawagishi 
et al., 1988; Giollant et al., 1993). The isolation of dimeric lectins from the 
mushrooms Agaricus edulis, Lactarius deterhmm, Lactarius deliciosus and 
lschnoderma resinosvs has been reported (Kawagishi and Mizuno, 1988; Kawagishi [ 
et al., 1988; Giollant et al., 1993). 
1； i  
The two T. motigolicmn lectins exhibited high thermal stability. Their \. 
h 
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hemagglutinating activities were stable between 1 0 ° C and 80°C. However, the [' 
activity of a sialic acid-binding lectin from the mushroom Hericium eruiacetim was 
stable only when the temperature was below 7 0 ° C (Kawagishi et al., 1994). Most 




T M L - 2 when colorimetric determination with the anthrone method and staining with 
periodic acid-Schiff reagent were performed. Two nonglycoprotein lectins have been 
isolated from the mushrooms Laeliporus sulfureys (Konska et al., 1994) and 
Lactarws deterriiiws (Giollant et al., 1993). The hemagglutination activities of 
T M L - 1 and T M L - 2 were not affected by demetalization, nor after addition of CaCb 
and MgCl2, but were mostly (75%) destroyed when 1 mM ZnCI2 or MnCl2 was 
f 
added. The activities ofboth lectins were relatively stable to the lower concentration 
of NaOH (0.025-0.05 N) but were almost completely destroyed by higher 
concentration ofNaOH (0.1 N). 
T M L - 1 and TML-2 share a lot of common characteristics, including a 
dimeric structure, similar molecular weights, sensitivity to lactose inhibition, not 
afFected by cations and thermal stability. However, their amino acid compositions are 
distinct. There is a marked difference in the content of proline and tyrosine residues. 
T M L - 2 possessed a more potent hemagglutination activity than TML-1 , whereas 
T M L - 1 possessed a more potent antiproliferative activity against PU5-1.8 cells than 
TML-2 especially in the presence of serum. An attempt has been made to use affinity 
chromatography on a-lactose-agarose gel for purifying these two lactose-specific 
lectins in this study. However, the affinity of the gel for the lectins was weak. It may 
be due to the fact that it requires a relatively high concentration of lactose (25 mM) 
to inhibit the lectins. 
The two lectins possessed specific antiproliferative activity /•// vilro. They 
brought about a dose-dependent inhibition of proliferation of PU5-1.8 and P815 




lines. Lectins are known to bind specifically to mono- and oligosaccharides on the 
cell surface. They react with cells which possess the "receptor" (Sharon and Lis, 
1972). 
T M L - 1 and T M L - 2 possessed similar antiproliferative activities against 
mouse mastocytoma P815 cells. Proliferation of the tumor cells was repressed 
significantly in the absence of fetal bovine serum. However, in the presence o f 2 . 5 % 
serum, their activities were markedly inhibited, and when the serum concentration 
was increased to 5 % and 10%, the activities were completely abolished. Fetal bovine 
serum contains complex glycoproteins which may constitute the binding sites for 
lectins. The inhibitory effect of serum has been studied on Agaricus bisponts lectin 
(ABL) (Yu et al., 1993). Inhibition by ABL ofHT29 cells (human colon cancer cell 
！ 
line) proliferation was observed in the presence of 2 % serum but an approximately 
20-fold higher lectin concentration was required to demonstrate an equivalent 
inhibitory effect than that observed in the absence of serum (Yu et al., 1993). Some 
lectins isolated from mushrooms exhibited antiproliferative activity against tumor 
cells, for example, Grifola frondosa lectin was cytotoxic against Hela cells 
(Kawagishi et al., 1990) and Volvariella volvacea lectin exhibited antitumor activity 
against Sarcoma 180 cells (Lin and Chou, 1984). Both T. mofigolictnn lectins, TML-
1 and TML-2, possessed potent antiproliferative activity against mouse monocyte-
macrophage PU5-1.8 cellls. In the presence of normal serum concentration (10%), 
about 5 3 % of the antiproliferative activity of T M L - 1 (40 ^ig/ml) against PU5-1.8 | 
5 7 
was still left. Thus these two lectins deserve to be studied as potential antitumor 
agents. 
3.5. Summary 
Two lectins, T M L - 1 and TML-2, were isolated from Tricholorna 
mongolicum mycelia by ion exchange chromatography and gel filtration. They are 
dimers with molecular weights of approximatly 37,000. The hemagglutinating 
activities o f T M L - l and TML-2 are sensitive to lactose inhibition and are stable 
between 10°C and 80°C. The two lectins differ in the content of proline and tyrosine 
residues. Both are nonglycoproteins and have hydroxyproline residues. They do not 
differ appreciably in their pH stability and cationic requirement for hemagglutinating 
activity. They exhibit antiproliferative activities against mouse monocyte-










Table 3.1. Hemagglutinating activities of T. morigolicum chromatographic 
fractions and lectins (from 1 kg of fresh mycelium) against rabbit erythrocytes 
Fraction Yield Specific hemagglutinating Recovery of 
(mg) activity (titer/mg) activity ( % ) 
Caide powder 4036 160 100 
Fraction A 19 0 0 
Fraction B 51 0 0 
Fraction C 97 160 2.4 
j 
Fraction D 325 1280 64.4 
I 1 
Fraction E 1276 160 31.6 
FractionDl 17 320 0.8 | 
Fraction D2 48 7530 56.0 
Fraction D3 92 80 1.1 
Lectin T M L - 1 6 11080 10.3 








Table 3.2. The hemagglutination titers of acid- and alkali-treated T. 
mofigolicnm lectins 
HCl (N) NaOH � 
i 
0 . 0 2 5 ~ ~ 0 ^ 0"i~~~ 0.025 005 ^ 1 ~ ~ 
! 
r! 
TML-1* 32 32 32 512 256 1 | 
TML-2* 16 16 16 256 256 0 | 











Table 3.3. Amino acid compositions of T. niongoliami lectins ( T M L - l and TML-2) and five 
other mushroom lectins. The values are expressed as molar % of the total number of amino 
acid residues. 
Amino acid mol % 
T M L - l T M L - 2 GFL(1)* HEL(2)* IRL(3)* F F L (4)* MOL (4)* 
Asx 13.74 12.82 01 72 i ^ UA FTz~ 
Thr 9.81 10.70 8.1 4.8 9.9 5.9 7.3 
Ser 6.11 4.89 11.0 9.1 5.7 5.3 6.8 
Glx 10.08 11.38 11.3 10.1 7.1 8.4 6.6 
Pro 5.31 2.69 7.6 3.5 4.5 3.0 3.3 
Gly 10.26 9.97 10.1 16.1 11 .1 10.9 7.4 | 
Ala 8.08 6.78 8.4 6.1 4.6 10.0 8.5 
Val 8.55 9.08 4.6 7.7 12.1 6.9 7.9 
Met 0.32 0.11 1.0 3.1 1.1 2.5 2.9 
Ile 5.09 5.23 2.6 5.9 2.8 5.4 6.9 
Leu 6.66 5.76 5.4 4.1 8.9 6.2 6.3 
Tyr 2.96 5.11 3.7 2.5 6.1 1.5 2.9 | 
Phe 4.38 4.51 2.0 3.9 2.2 4.8 6.6 j 
His 0.93 0.71 2.8 2.7 1.0 3.8 2.1 t 
Lys 3.38 4.18 3.2 6.5 6.4 6.5 3.6 
Arg 4.34 6.09 5.1 3.9 1.5 2.1 1.7 
Cys N D ND N D N D 2.2 1.2 1.2 
Trp N D N D ND N D 2.4 3.2 4.4 
|r 
I 
ND: not determined; GFL: Grifola frondosa lectin; HEL: Hericinm erinaceum lectin; JRL: 秦 
Ischnoderma resinosus lectin; FFL: Fomes fomentarms lectin and MOL: Marasmius oreades 
lectin. *The number in parentheses represents the reference: (!) Kawagishi et al., 1990; (2) 
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Figure 3.1. Photograph of the cultured colony of Tricholoma mongolicum. 
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Figure 3.2. Drawing of the fruiting body of T. Mongolicnm (provided by | 
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Figure 3.3. Anion-exchange chromatography of cmde powder on a D E A E -
cellulose column which was eluted stepwise with 5 mM, 50 mM, 150 mM 
and l M ammonium bicarbonate bufTer (pH 9.0). Five peaks designated A, 
B, C, D and E respectively were detected. Arrows indicate the points at 
which bufTer was changed. 
64 
D2 
iiM^ 0 ( ^ ^ ! 1 1 > " ^ 
0 10 20 30 40 50 60 70 80 
Elution volume (ml) 
Figure 3.4. Gel filtration of fraction D on a Sephadex G-lOO column which was 
eluted with 50 mM ammonium bicarbonate bufTer (pH 9.0) to yield three 
peaks designated as D l , D2 and D3. 
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Figure 3.5. Cation-exchange chromatography of fraction D2 on an SP-
Sepharose column which was first eluted witli 10 mM ammonium acetate 
buffer (pH 5.5) and then with a linear gradient of 0-0.5 M sodium chloride 
in tlie buder. Two lectins, T M L - 1 ancl TML-2, were obtained. 
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Figure 3.7. Gel filtration of T M L - 1 and T M L - 2 with a GradiFrac system on a 
Superdex 75 column (HiLoad 16/60). The molecular weight markers used 
were: (1) bovine serum albumin, (MW 67,000); (2) ovalbumin, (MW 
43,000); (3) chromotrypsinogen A (MW 25,000); and (4) cytochrome C 
(MW 12,400). The molecular weight of both T M L - 1 and T M L - 2 was 
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Figure 3.8. Photograph of SDS-PAGE of T. mongolicnni lectins T M L - 1 and 
TML-2 in the presence of 2-mercaptoethanol. From the left: lane 1 
showing the molecular weight markers (from the top downward : 
phosphorylase b, MW 94,000; bovine serum albumin, MW 67,000; 
ovalbumin, MW 43,000; carbonic anhydrase, MW 30,000; soybean trypsin 
inhibitor, MW 20,100 and a-lactalbumin, MW 14,400), lane 2 showing 
T M L - 1 and lane 3 showing TML-2. 
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Figure 3.9. Molecular weight determination of T. mongoiiciim lectins TML_1 
and TML-2 using SDS-PAGE in the presence of 2-mercaptoethanol. The 
molecular weight markers used were: (1) phosphorylase b (MW 94,000); 
(2) bovine serum albumin (MW 67,000); (3) ovalbumin (MW 43,000); (4) 
•carbonic anhydrase (MW 30,000); (5) soybean trypsin inhibitor (MW 
20,100), and (6) a-lactalbumin (MW 14,400). The molecular weight of 
the subunits ofboth TML-1 and TM.L-2 was 17,500. 
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Figure 3.10. Antiproliferative activities of T. wongoHcum lectins T M L - 1 and 
T M L - 2 against mouse mastocytoma P815 cells /•// vilr() in the presence 
and absence of fetal bovine semm. Results are presented as mean 土 
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Figure 3.11. Antiproliferative activities of TML-1 and TML-2 against mouse 
mastocytoma P815 cells /•// vitro in the presence of different 
concentrations of fetal bovine semm. The activities were nearly 
completely suppressed in the presence of 5 % or 1 0 % fetal bovine semm. 
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Results are presented as mean 士 standard deviation (n = 3). 
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Figure 3.12. Antiproliferative activity of 7: m()iigoliain, lectin T M L - 1 against 
mouse monocyte-macrophage PU5-1.8 cells /.// vitro in the presence and 
absence of fetal bovine serum. Results are presented as mean 士 standard 
deviation (n = 3). 
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Figure 3.13. Antiproliferative activity of T. mougohcum lectin T M L - 2 against 
mouse monocyte-macrophage PU5-1.8 cells /// vHro in the presence and 
absence of fetal bovine serum. Results are presented as mean 士 standard 
deviation (n = 3). 
74 
1 2 n 
10 - T T 
. n v ^ 
0 = = 
.5 8 - ^ S 
Ui ^ ^ = 
i - I _ 
1 ^ 6 - • — 1 丨 
<D 0 ^ ^ 
C o = 
• ^ > 4 ^ _ r f •• • 一 
T3 二 ^ ^ no 
1 ¾ 棚 
•6 4 - _JL_ T T T T ^ ^ E35 
I 丨 ltTitt mm ^^^= 
X ^ ^ _ ^ 
“ ^ ^ H ^ g mo 
2 I 1 ^ ¾ B20 
I I ^ ^ g ffl40 
0 -I ^ mmm—, ^ ^隱 1 — — , 
No serum 5 % semm 
Figure 3.14. Lack of significant cliange in proliferative activity of mouse sarcoma 
180 cells after co-incubation with T M L - 1 for 48 hr in the concentration 
range of 5-40 |,ig/ml in vHro. Results are presented as mean 土 standard 
deviation (n = 3). 
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Figure 3.15. Lack of significant change in proliferative activity of mouse sarcoma 
180 cells after co-inciibation with T M L - 2 for 48 lir in the concentration 
range of 5-40 |_ig/nil /•//、，ilr(). Results are presented as mean 土 standard 
deviation (n = 3). 
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Figure 3.16. Lack of significant change in proliferative activity of mouse 
monocyte-macrophage P388D1 cells after co-inciibatioii with T M L - l for 
48 hr in the concentration range of 5-40 |ig/ml /// vi/ro. Results arc 
presented as mean 土 standard deviation (n = 3). 
77 
12 n 
8 _ 丁 T T 丄 
c T . ^ = 
o ^ = 
15 ^ ^ = 
u. ^^^E 
& f 6 - • 
0 Pn ^ ^ = , , 
^ 0 ^ = |ig/ml 
.5 o ^ ^ 
. ! § T 圍 
1 X 4 - r J U 了 ^ J L J | M 義 D O 
•^、 I I ^^p V ^ q • ms 
K I I ^ ^ 
� 2 - 圍 震 D 1 0 
^ m • 目20 
� • ^ B 震 _ , 皿40 
0 H 1 " “.""' ^ ^ ^ 1 ‘ 
No semni 5 % serum 
Figure 3.17. Lack of significant change in proliferative activity of mouse 
monocyte-macrophage P388DI cells after co-incubation vvith TML-2 for 
48 hr in the concentration range of 5-40 ^g/ml /•// vitm. Results are 
presented as mean 土 standard deviation (n = 3). 
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C H A P T E R 4 
The Immunomodulatory and Antitumor Activities of 
Lectins from the Mushroom Tricholonia mongoliami 
4.1. Introduction 
Lectins have been used as probes for characterization of structure and 
organization of glycoconjugates on the cell surface and the change they undergo 
during differentiation and malignant transformation (Sharon, 1983). The role of 
lectins and glycoconjugate in various cellular processes is receiving increasing 
interest, and several studies have focused on lectin-induced signal transduction and 
responses as well as on cellular adhesion and recognition involving lectin-
glycoprotein interaction (Sharon and Lis, 1989; Beuth et al., 1995). The 
phenomenon of lectin-lymphocyte interactions is important in highlighting the 
intricacies of cellular interactions, soluble mediator involvement and receptor 
signalling mechanisms if an understanding of the immune response in vivo is desired 
(Kilpatrick, 1995). Lectins can be classified into mitogenic and non-mitogenic 
7 9 
groups and it has been suggested that the essential difference between the two 
groups of lectins lies in the observation that only the former group binds to the T3 
(CD3) molecule, to the histocompatibility antigens, or to the T-cell receptor 
(Fleischer, 1984). Evidence also exists that some lectins can induce a mitogenic 
response via CD2, the T-lymphocyte receptor for sheep erythrocytes, through an 
alternative pathway of activation. Furthermore, lectin-carbohydrate interactions 
represent a common and important feature of molecular events underlying the 
immune response (Drickamer and Taylor, 1993; Kennedy et al., 1995). 
The involvement of many lectins in the immune response of humans and 
animals, and antiproliferation of tumor cells in vitro and in vivo have been 
demonstrated (Hajto et al., 1990; Beuth et al., 1991; Yu et al., 1993; Chen et al., 
1994; Ko et al., 1995). Two lectins, T M L - 1 and TML-2, which have been isolated 
from the mycelium of the edible mushroom Tricholoma niongoliaim, brought about 
a dose-dependent inhibition of proliferation of PU5-1.8 and P815 tumor cells, but 
did not inhibit the growth of Sarcoma 180 and P388D1 tumor cell lines />? vitro 
(Wang et al., 1995b). In the present study, the effects o f T M L - l and TML-2 on the 
mitogenic response in vitro and in vivo, production of nitrite ion and tumor necrosis 
factor (TNF), antitumor activity and survival time in the tumor-bearing mice were 
examined. 
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4.2. Materials and Methods 
4.2.1. Lectins 
Two lectins, T M L - 1 and T M L - 2 , were isolated from the mycelium of T. 
mongolicum and purified by ion exchange chromatography and gel filtration as 
described in Chapter 3. 
4.2.2. Animals 
Male inbred C57BL/6 and B A L B / c mice, 8 - 12 weeks old, were used in this 
study. The animals were housed under normal laboratory conditions ( 2 1 ± 2 ° C , 12/12 
h light/dark cycle) and maintained on standard rodent chow and water ad lihitum. 
4.2.3. Assay for antitumor activity 
Sarcoma 180 cells maintained in the peritoneal cavity of male B A L B / c mice 
were used for the antitumor activity assay. A mouse was sacrificed on the seventh 
day after inoculation oftumor cells and the ascitic fluid was collected. After the cells 
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were washed three times with PBS, the cell suspension was diluted to 5 x 10 
cells/ml, and 0.1 ml of the suspension was subcutaneously inoculated into the back 
ofeach B A L B / c mouse (Wang et al., 1995a). 
The tumor-bearing mice (6 mice/group) were treated, after tumor cell 
inoculation, by daily intraperitoneal injection o f T M L - 1 and T M L - 2 (1 mgy^ ml) for 20 
days at the dosage of 5 mg/kg body weight/day. The control group was treated with 
phosphate-buffered saline. On the twenty-first day after inoculation of tumor cells, 
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the mice were sacrificed and their solid tumors were excised and weighed. The 
tumor inhibition activity was calculated as follows (Kim et al., 1992; Yang et aI., 
1992): 
% Tumor inhibition = (C-T)/C x 100% 
where C = average tumor weight of the control group and 
丁 = average tumor weight of the lectin-treated group 
4.2.4. Assessment of tumor growth and host survival after lectin treatment 
BALB/c mice were divided into groups (10 mice/group) and inoculated by an 
intraperitoneal injection of0.1 ml of cell suspension containing either 5 x 10^ or 1 x 
10^ Sarcoma 180 tuinor cells/mouse. The tumor-bearing mice were then treated by 
an intraperitoneal injection o f T M L - l or TML-2 (1 mg/inl), at the dosage of 5 mg/kg 
body weight/day, until half of the mice in the control group which was treated with 
PBS had died. The growth of tumor cells was evaluated by monitoring the body 
weight change on a balance. The life-span of each mouse was also noted (Eckhardt 
et al., 1982; Lin and Chou, 1984; Ganguly and Das, 1994). 
4.2.5. Mitogenic activity oflectins 
In vitro study. T-cells were isolated from splenocytes of normal C57BL/6 
mice in the flasks coated with anti-B cells antiserum (Wang et al., 1996c). 
Macrophages were removed by adherence on the culture well for 2 hr. The purity of 
the preparation of T-cells exceeded 95% as estimated by immunostaining. The cell 
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suspension was diluted with RPMI medium which contained different concentrations 
of fetal bovine serum (0，2.5, 5 and 10%) and the cells were then seeded (2 x 10^ 
cells/well/0.2 ml) in 96-well microplates. T M L - 1 and T M L - 2 were added at the 
concentrations of 0, 5, 10, 20 and 40 ^ig/ml. Cells cultured in the absence of lectin 
were used as control (CTL) and concanavalin A was employed as a positive control. 
The cells were incubated at 37°C in a humidified atmosphere of 5 % CO2 for 48 h. 
During the last 6 hr, the cells were pulsed with 0.5 ^iCi/10 ^il/well of ^H-methyl-
thymidine (specific activity 5 nCi/mmole, Amersham, England). The cells were then 
harvested onto a glass fiber filter with a cell harvester, and the radioactivity was 
measured using a Beckinan scintillation counter (Liu et al., 1996b). The proliferative 
response was expressed as mean counts per minute (CPM). The mitogenic activities 
ofboth lectins toward splenocytes were determined as described for T-cells. 
hi vivo study. T-cells were isolated as in the in vilro study from the normal 
or tumor-bearing C57BL/6 mice (subcutaneously inoculated 5 x 10^ Sarcoma 180 
cells/0.1 ml/mouse), which, however, had been pretreated by intraperitoneal 
injections with TML-1 and TML-2 (1 mg/ml) at the dosage of 5 mg/kg body 
weight/day for 7 days. The control group was treated with phosphate-buffered 
saline. Their mitogenic response was determined as described above with the 
addition ofconcanavalin A (Con A) (Liu et al., 1989). 
4.2.6. Production of nitrite ions in response to lectin treatment 
Three days after eliciting by 3 % thioglycolate, the peritoneal macrophages 
were collected from the normal and tumor-bearing (subcutaneously inoculated with 
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Sarcoma 180 cells as described above) C57BL/6 mice which had been pretreated 
with either T M L - 1 or T M L - 2 as described in the last paragraph. The cells were 
washed, counted and resuspended in D M E M culture medium devoid ofphenol red 
but supplemented with 1 0 % fetal bovine serum (FBS), 100 IU/ml penicillin and 100 
pig/ml streptomycin. The cells (2 x 10^ cells/well/0.2 ml) were permitted to adhere 
onto the surface of the wells of a 96-well culture plate for 1 h before they were 
challenged with lipopolysaccharide (LPS, 1 ^g/ml) for 24 h. Nitrite ions WO2") in 
the culture medium were quantitated with the colorimetric method of Keller et al. 
(1990) using NaNO2 as a standard (Liu et al., 1993b; Ohno et al., 1996). An aliquot 
(100 pil) of the cell-free culture medium was removed from each culture well and 
mixed with 50 i^l of Griess reagent ( l % sulfanilamide in 5 % H3PO4-O. l% 
naphthalene-ethylenediamine dihydrochloride) for 10 min. Absorbance was then read 
at 540 nm using a microplate reader (Bio-Rad, USA) (Keller et al., 1990). 
4.2.7. Preparation of Con A-stimuIated lymphokines 
Normal spleen cells (2 x 10^ cells/20 ml) from C57BL/6 mice were cultured 
in R P M I medium supplemented with 1 0 % FBS, 100 IU/ml penicillin and 100 ^ig/ml 
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streptomycin in a 75 cm -culture flask in the presence of 10 |igAnl concanavalin A 
(Sigma, USA) for 3 h. The culture medium was removed, and the lymphocyte 
monolayer was rinsed carefully with warm PBS to remove excess Con A. The cells 
were further incubated for an additional 24 h at 37°C with 20 ml of freshly 
supplemented RPMI medium. After incubation, the cell-free culture medium was 
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sterilized by passing through a 0.22 i^m MilIipore filter and the lymphokine-
containing medium was collected for macrophage activating factor assay (Liu et al., 
1989). 
4.2.8. Assay for macrophage activating factor 
The tumoricidal activity of macrophage was assayed as described by Liu et 
al. (1989). The macrophage activating factor measured includes interferon-y mainly 
but may also include some other cytokines. Peritoneal cells were collected after 
eliciting by thioglycolate for 3 days from the mice which had been pretreated with 
T M L - 1 , T M L - 2 and PBS (control group). The cells were rinsed, counted and 
resuspended at 5 x 10^ cells/ml supplemented RPMI. Aliquots (0.2 ml) of the cell 
suspension were allowed to adhere onto 96-well culture plates at 37°C for 3 h. The 
culture wells were washed vigorously with warm PBS to remove non-adherent cells, 
and the adherent macrophages were activated by incubation with lymphokine 
preparations for 24 h. The tumoricidal activity of the activated macrophages was 
assayed by further incubation of the macrophages with P815 mastocytoma cells 
( A T C C T I B 64) for 24 h at different ratios. The cultures were pulsed for 6 h with 
0.5 ^iCi ^H-methyl-thymidine (specific activity 5 nCi/mmole, Amersham, England), 
and the uptake of ^H-methyl-thymidine by P815 cells was determined using a 
Beckman scintillation counter. The tumoricidal activity was calculated as follows 
(Wang et al., 1995a): 
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Tumoricidal activity ( % ) = (A-B)/A x 100% 
where A = average counts per minute of control sample and 
B = average counts per minute oflectin-treated sample 
4.2.9. Production of tumor necrosis factor (TNF) 
Adherent peritoneal macrophages (1 x 10^ cells/ml RPMI/ well) from both 
lectin-treated and control C57BL/6 mice were cultured in the presence of 1 ^igAnl of 
LPS for 30，60, 90, 120 and 150 min. The cell-free TNF-containing medium was 
collected, sterilized by passing through a 0.22 fim millipore filter, and stored at 
- 7 0 � C before use (Liu et al., 1993a). 
4.2.10. Bioassay for tumor necrosis factor 
T N F was measured using an L929 mouse fibroblast assay (Liu et al., 1993a). 
Briefly, L929 cells (1 x 10^ cells/0.1 ml) were cultured in 96-well culture plates for 
24 h at 37°C, treated with 2 fig/ml actinomycin D (Sigma, USA) for 2 h and further ‘ 
I 
incubated with 0.1 ml TNF-containing culture medium (1:200 dilution, V / V ) for 24 
h. The viability of adherent cells was measured by staining with 0.1 ml of crystal 
violet solution (0.5 % in methonal/water [1:4 v/v]) for 5 min, rinsing 3 times with 
warm PBS containing Ca]+ and Mg�+, extracting with acetic alcohol and then reading 
the absorbance of each well at 595 nm with a microplate E L I Z A autoreader (3550 
Bio-Rad Microplate reader, USA). The bioactivity was defined as percent inhibition 




Data were analyzed using one-way analysis of variance and matched-pair 
comparisons were further made by Student's /-test (one-tailed). The level of 
significance was taken at P < 0.05. 
4.3. Results 
4.3.1. Antitumor activity 
The effects of the two lectins against Sarcoma 180 growth in BALB/c mice 
are shown in Table 4.1. The percentages of tumor growth inhibition caused by T M L -
1 and T M L - 2 were 68.84% and 92.39%, respectively. 
4.3.2. Assessment of tumor growth and host survival 
1 
The survival time of BALB/c mice which had been inoculated with Sarcoma 
I 
180 cells, with or without subsequent lectin treatment, is shown in Table 4.2. The | 
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mice in the control group, each of which was challenged with 5 x 10 tumor cells, 
had an average survival time of 10.3土2.2 days (mean 土 SD) and the lectin-treated 
groups receiving T M L - 1 or TML-2 had a life-span increased by 2 9 . 1 % and 45.6% 
respectively. Mice which were challenged with 1 x 10^ tumor cells per mouse had an 
average survival time of 16.2±3.4 days (mean 土 SD). and the growth of tumor cells 
in the lectin-treated groups was completely suppressed by the lectins. 
The average body weight change in each group was used to monitor 
Sarcoma 180 cell growth /// vivo. Fig. 4.1 shows the effects of the two lectins on the 
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growth of tumor cells. The body weight of the control group increased steadily but 
those of the lectin-treated groups did not undergo any remarkable changes except 
for a decrease at the beginning. 
4.3.3. Mitogenic activity 
In vitro study. When the mitogenic activities o f T M L - 1 and T M L - 2 toward 
T-cells were determined in vitro, it was found that both lectins only slightly 
enhanced the proliferation ofT-cells at the concentrations of 5-40 i^gAnl，in contrast 
to the prominent effect of Con A in the presence of 2 .5 - 10% fetal bovine serum 
(FBS) (Fig. 4.2-4.4). For example, in the presence of 1 0 % o f F B S and 20 |igAnl of 
lectin, tritiated thymidine uptake in response to treatment with Con A, T M L - l and 
T M L - 2 was respectively 25.4, 1.7 and 2.8 folds higher than the control value. In the 
absence ofFBS, the proliferative response of T-cells was very weak (Fig. 4.5). The 
results ofthe mitogenic response of spIenocytes toward both lectins were similar to 
those of T-cells (Fig. 4.6). 
Jn vivo study. The mitogenic response of T-cells from the normal C57BL/6 
rnice pretreated by an intraperitoneal injection of T M L - l or TML-2 at 5 mg!kg 
body weight/day for 7 days is shown in Figure 4.7. Neither T M L - l nor TML-2 
stimulated the proliferation of T-cells at the Con A concentrations of 5-40 ^g/ml 
when compared with the control. On the contrary, they significantly inhibited the 
uptake oftritiated thymidine at the Con A concentrations of 5-40 figAnl for T M L - l 
and 10-40 \ig/m\ for TML-2 respectively (Fig. 4.7). 
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When the mitogenic response of T-cells from the tumor-bearing C57BL/6 
mice was determined, it was found that the presence of tumor cells markedly 
inhibited the proliferation of the T-cells. The responses ofboth lectin-treated groups 
were similar to the tumor-bearing control group (Fig. 4.8). . 
4.3.4. Production of nitrite ions 
After the normal C57BL/6 mice had been pretreated with T M L - 1 and T M L -
2, NO2 production by the peritoneal macrophages upon LPS stimulation was 
markedly higher than that of the control, especially in the case of the TML-2 treated 
group (Fig. 4.9). The nitrite ion production of the tumor-bearing mice was higher 
than that of the normal mice. Both lectins significantly stimulated NO2' production ‘ 
ofthe tumor-bearing C57BL/6 mice (Fig. 4.10). , 
I 
I 
4.3.5. Production of macrophage activating factor 
! 
An /•//�"V<7 assay for the inhibition of tumor cell growth by activated , 
macrophages was used to estimate the ability of the two 7： mongolicnm lectins to 
stimulate mouse macrophages. When macrophage : P815 ratio was 2.5 : 1, only 
T M L - 2 markedly inhibited the growth of tumor cells. When the ratios of 
macrophage : P815 between 5 : 1 and 40 : 1 were employed, the growth of tumor 
cells was significantly inhibited by the two lectins when compared with the control 




4.3.6. Tumor necrosis factor assay 
In order to study whether both lectins could stimulate the production of 
TNF, macrophages collected from the Iectin-treated mice were stimulated in vitro 
with lipopolysacchride for 30 to 150 min and the level o f T N F in the culture medium 
was measured with a bioassay employing the L929 fibroblast cell line. Figure 4.12 
shows that the basal levels o f T N F ofboth the lectin-treated and the control groups 
/ 
were similar. However, a significant (P < 0.05) increase o f T N F was produced by the 
lectin-treated groups, especially by the TML-2-treated group. The most prominent 
increase was observed after 60 min of treatment. 
4.4. Discussion 
Saccharide determinants present on cell surface glycoconjugates serve as 
important binding sites for specific lectins, exerting modulatory influences in the 
immune system. Such mediatory factors with carbohydrate specificity may be 
potentially exploitable for therapeutically beneficial manipulation of the host's ability 
to attack malignant cells (Sharon and Lis, 1989; Beuth et aI., 1995). In the search of 
immunomodulatory substances, plant and fungal extracts provide a readily available 
and rich source (Hajto et al., 1990). In the present study two lectins, T M L - 1 and 
TML-2, were isolated from the mycelium of T. mongolicym. They possessed the 
immunomodulatory activities by stimulating the production of nitrite ion O^O2') and 
activating macrophages in mice to produce tumor necrosis factor and macrophage 
activating factor. T M L - 1 and TML-2 were able to increase the life-span of tumor-
bearing mice which had been inoculated with Sarcoma 180 cells by intraperitoneal 
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injection, and reduced by 68.84% and 92.93% respectively the growth of tuinor cells 
implanted in mice by subcutaneous inoculation. Eckhardt et al. (1982) have shown 
that Griffonia simplicifoUa 1 lectin inhibited Ehrlich ascites tumor cell growth in 
mice as reflected by the body weight change. The lectin also increased life-span in 
the tumor-bearing mice. 
T M L - 1 and T M L - 2 exhibited specific antiproliferative activity against tumor 
cell lines but they did not inhibit the growth of Sarcomal80 in vitro as described in 
Chapter 3. The antitumor activity against Sarcoma 180 cells in vivo indicated that 
these two lectins were iminunoinoclulatory substances rather than substances 
exerting direct cytotoxicity. The antitumor activity against Sarcoma 180 cells inay be 
a consequence of immunostimulation and not a result of direct antiproliferative 
activity (Liu et al., 1993a). 
Macrophages and lymphocytes are two major populations of cells in the host 
defense system which combat invading pathogens (Benjamini and Leskowitz, 1991). 
Macrophages are responsible for the non-specific cellular response. They engulf 
infectious microorganisms and digest them with lysosomal lytic enzymes. 
Macrophages can be activated by lymphokines and other cell inediators to destroy 
tumor cells by generating tumor necrosis factor and nitrite ions. The nitrite ions are 
formed from the oxidation of nitric oxides which are extensively labile and may play 
a vital role in the tumoricidal activity of macrophages because it produces a 
suppressive effect on Sarcoma cell growth by inhibiting the energy-producing Krebs 
cycle and electron transport activities as well as DNA synthesis (Snyder, 1992). TNF 
is a pluripotent mediator in activating immune cells. When non-specific responses fail 
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to halt the invasion of pathogenic organisms, specific immune responses are 
activated whereby the lymphocytes recognize a particular pathogen and generate 
antibodies to promote destruction of this pathogen. In addition, lymphocytes and 
macrophages collaborate through the production of cell mediators (Keller et al., 
1990; Liu et al., 1993a). Thus it was of interest to study the effect of lectins, 
especially mushroom lectins, on these two types of cells in the immune system. 
T M L - 1 and T M L - 2 possessed only slight mitogenic activities toward T-cells 
or splenocytes from the normal C57BL/c mice in vitro. However, they did not 
stimulate the proliferation ofT-cells in vivo. When normal mice had been pretreated 
by an intraperitoneal injection of the lectins, the proliferation ofT-cells was inhibited. 
When sarcoma-bearing mice were similarly treated with lectins, T-cell proliferation 
was not affected when compared with the corresponding control. Both lectins 
stimulated the productin ofTNF, macrophage activating factor and nitrite ions when 
the normal or tumor-bearing mice had been pretreated by T M L - 1 and TML-2. The 
results indicate that T M L - 1 and TML-2 resemble each other in their activities on 
macrophages and lymphocytes. However, a stimulatory action was exerted by the 
lectins on the macrophages and not on the lymphocytes. 
Lectins have been demonstrated as potential preventive agents of cancer 
metastases and as therapeutic drugs (Sharon and Lis, 1972; Schumacher, 1995). The 
successful formation ofmetastases depends, at least partially, on the ability oftumor 
cells to express a certain repertoire of adhesive behavior. Such adhesive diversity 
enables tumor cells to detach from the primary tumor, travel through normal tissues, 
enter the blood stream, re-attach at places remote from the primary tumor and again 
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emerge from the vascular system and go into the normal tissue. Adhesion and 
inhibition experiments with parenchymal cells and tumor cells have indicated that 
lectins mediate specific cellular interactions. Both in vitro and in vivo adhesion of 
tumor cells to parenchymal cells could be inhibited by lectin-blocking 
glucoconjugates while non-specific glycoconjugates did not interfere with the 
adhesion process. Accordingly, when the action of organ-characteristic lectin was 
blocked by competitive receptor analogues, tumor colonization could be significantly 
reduced (Schumacher, 1995). 
Cancer chemotherapy using conventional chemotherapeutics is generally not 
very effective (Ochiai et al., 1992). Moreover, the side-effects, for example, 
suppressive effects on host immunity, are harmful due to accelerating induction of 
metastasis (Tsuru et al., 1991). The suppression of small numbers of autochthonous 
cancer cells scattered throughout the body of the host should be the focus of cancer 
treatment. The best way to attain this may be to potentiate host resistance against 
cancer so as to suppress the proliferation of cancer cells (Chihara, 1992). 
Polysaccharides and protein-bound polysaccharides with immunomodulatory and 
antitumor activities have been isolated from a variety of higher fungi, such as PSK 
(Tsuru et al., 1991), lentinan (Ochiai et al., 1992)，schizophyllan (Jong et al., 1991), 
polysaccharopeptide (PSP) (Liu et al., 1993a) and polysaccharide-peptide complex 
(Wang et al., 1995a) are effective growth inhibitors of Sarcoma 180 which has been 
implanted in mice. Their antitumor activities are attributed to stimulation ofthe cell-
mediated immune response. Several lectins isolated from plant or higher fungus 
possess immunomodulatory and antitumor activities (Beuth et al., 1991; Eckhardt et 
9 3 
al., 1982; Lin and Chou, 1984), and are under clinical trials (Beuth et al., 1992; 
1995; Kilpatrick, 1995). T M L - 1 and T M L - 2 possess specific antiproliferative 
activity against tumor cell lines in vitro and immunomodulatory and antitumor 
activities />/ vivo. Thus these two lectins deserve to be studied as potential agent for 
immunomodulation and cancer therapy. 
4.5. Summary 
T M L - 1 and T M L - 2 stimulated the production o f T N F and nitrite ions and 
activated the macrophages in mice. The two lectins were able to inhibit the growth 
ofimplanted Sarcoma 180 cells by 68.84% and 92.39% respectively. They exhibited 
only slight mitogenic activity toward T-cells or splenocytes from the normal mice in 
vitro when compared withCon A. However, the proliferation ofT-cells from normal 
mice which had been pretreated by an intraperitoneal injection of the lectins was 
inhibited. Similarly, T-cells from sarcoma-bearing mice treated with the lectins did 
not exhibit a proliferative response different from that of control. In mice the growth 
! 
of Sarcoma 180 cells in the peritoneal cavity was inhibited and the life-span was 
prolonged by the two lectins. 
9 4 
Table 4.1. Antitumor activities of lectins T M L - l and T M L - 2 against 
Sarcoma 180 
C T L T M L - l T M L - 2 
Average tumor 2.76 0.86* 0.21* 
weight (g) 土0.96 ±0.41 ±0.18 
Inhibition oftumor 0 68.84 92.39 
growth ( % ) 
* Level of significance at P < 0.05. The data are presented as mean ± 
standard deviation (SD). N = 6 mice/group and C T L = control. 
9 5 
Table 4.2. Effects oflectin treatment on survival ofS-180-bearing mice 
Treatnent Tumor cell challenge Median survival Increase in 
(cell no.) time (days) life-span ( % ) 
T M L - 1 5 X lC)6 13.3t2.9* ^ 
1 X 10^ >50** >200 
T M L - 2 5 x l 0 6 15.0±3.2* 45.6 
1 X 10^ >50** >200 
I I 
Control 5 x 10' 10.3±2.2 0 , 
I 
1 X 10^ 16.2±3.4 0 
I 
( < 
* Level of significance at P < 0.05. The data are presented as mean 土 < 
standard deviation, n=10. 
** The growth of tumor cells was completely suppressed and the mice 
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Figure 4.9. Production o f N O 2 ' by macrophages of normal C57BL/6 mice which 
had been pretreated by intraperitoneal injections of the lectins T M L - 1 and 
T M L - 2 at 5 mg/kg body weiglit/day for 7 days. The data are presented as 
mean 土 standard deviation. *P < 0.05 against control, n 二 6. C T L = 
normal mice, T M L - 1 and T M L - 2 = normal mice pretreated with T M L - 1 
and T M L - 2 respectively, 
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Figure 4.10. Production of NO2" by macrophages of tumor-bearing C57BL/6 
mice (subciitaneoLisly inoculated 5 x 10^ sarcoma 180 cells/0.1 inl/iiiouse) 
I 
which had been pretreated by intraperitoneal injections of lhe lectins 
T M L - 1 and T M L - 2 at 5 mg/kg body weight/day for 7 days. The data are 
presented as mean 土 standard deviation. *P < 0.05 against the 
tumorbearing control, n = 6. C T L = normal mice, C T L - T = tumor-bearing 
mice, T M L - l - T and T M L - 2 - T = tumor-bearing mice pretreated with 
T M L - 1 and T M L - 2 respectively. 
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Figure 4.11. Tumoricidal activity of macrophage activating factor-activated 
macrophages from C57BL/6 mice which had been pretreated with the 
lectins T M L - 1 and T M L - 2 at 5 ing/kg body weight/day for 7 tlays. The 
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Figure 4.12. Inhibition of L929 tumor cell growth by TNF-containing media 
produced by peritoneal macrophages from control and lectin-treated mice. 
Cultures were stimulated with lipopolysaccharide (LPS) for 0’ 30，60，90， 








Hypotensive and Vasorelaxing Activities of a Lectin (TML-1) 




5.1. Introduction 丨 
I 
A variety of mushrooms have been used traditionally in many different 
< 
cultures for the maintenance of health and for the prevention and treatment of ！ 
diseases such as cancer, viral disease, hypercholesterolemia, blood platelet f 
« 
aggregation and hypertension (Breene, 1990; Kim et al., 1990; Jong et aI., 1991; 
Chihara, 1992; Wang et al., 1995a). Edible mushrooms including Grifolafrondosa, 
Lentimis edodes, Ganoderma luddum (Breene, 1990), Plem'otm sajor-caju (Tam et 
al.，1986) and Volvariella volvacea (Chiu et al., 1995) have been reported to 
demonstrate hypotensive effects. Feeding powdered G. frondosa to the 
spontaneously hypertensive rat resulted in a lowering of blood pressure (Adachi et 
al.，1988). An aqueous extract o fP . sajor-caju exhibited a hypotensive effect in rats 
0 
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and a typical dose of 25 mg/kg body weight decreased the MAP from ] 10 to 70 
mmHg (Tam et al., 1986). 
Blood pressure is generated by forceful contraction of the heart so as to 
pump blood in the circulation to every part of the body to provide nutrients. Blood 
pressure is defined as the force that the blood exerts against the walls of the blood 
vessels (Sperelakis and Banks, 1993). Blood pressure is altered basically by two 
important factors. They are cardiac output (stroke volume x heart rate) and 
peripheral vascular resistance (Ammons, 1983). Volume of venous blood returning 
to the heart, the size of the heart, contractile strength of the heart, and also the rate 
of the heart beat affect the stroke volume. The peripheral resistance is inversely 
proportional to the diameter of the blood vessels and directly proportional to the 
viscosity of the blood. One may expect that the arterial pressure changes if any one 
of the above factors changes (Guyton et al., 1981). 
Hypotensive drugs are divided into 7 classes according to their mechanisms 
of action. They are (1) drugs interacting at a-adrenoceptor sites, (2) P-adrenoceptor 
antagonists, (3) drugs interacting with the autonomic nervous system by mechanisms 
other than (1) and (2), (4) inhibitors of the renin-angiotensin system, (5) diuretics, 
(6) vasodilator antihypertensives, and (7) dmgs with miscellaneous mechanisms 
and/or sites of action (Rang and Dale, 1991). 
The basic mode of action of hypotensive drugs is to act as agonists or 
antagonists on receptors. An agonist is designated as a drug, hormone or a 
transmitter substance that elicits a cellular response when it combines with its 
• 
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receptors. An antagonist is a dmg that prevents the effect of an agonist. Sometimes, 
antagonists are known as blockers (Rang and Dale, 1991; Shum and Chiu, 1991). 
Some lectins manifest hypotensive activity. Ricin is a toxic lectin isolated 
from the castor bean and it could lower blood pressure (Christiansen et al., 1994; 
Zhang et al., 1994). Three other plant lectins, namely, wheat germ agglutinin, 
concanavalin A and lentil agglutinin, were also shown to relax the coronary arterial 
and/or aortic rings by enhancing the production of endothelium-derived relaxing 
factor (Kleha et al., 1991, 1993). 
In the present study, a preliminary screening test for cardiovascular activity 
of the two lectins (TML-l and TML-2) and a polysaccharide-peptide complex 
isolated from the edible mushroom Tricholoma mongoliaim was carried out. TML-l 
was found to be the most potent hypotensive agent among these biologically active 
substances from the mushroom T. mongolicutii. Therefore, the hypotensive action of 
TML-l (a lectin) was determined in normotensive rats, and the possible mechanism 
of its hypotensive action was also investigated using various pharmacological 
parameters and antagonists. 
5.2. Materials and Methods 
5.2.1. Animals 
Male Sprague-Dawley rats (SD rats) weighing 260-280 g were provided by 
the Animal House of the Chinese University ofHong Kong. They were housed under 
normal laboratory conditions (21±2°C, 12/12 hours light/dark cycle) and maintained 
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on standard rodent chow and water ad libitum. Five rats per group were used for 
each of the experiments described below except for blood pressure measurement in 
which 10 rats per group were used insteat. 
5.2.2. In vivo blood pressure measurement in rats 
The rats were anaesthetized with sodium pentobarbital (50 mg/kg body 
weight) using an intraperitoneal (i.p.) injection. The body temperature was 
maintained with a table lamp. The left carotid artery was exposed, and cannulated 
with a polyethylene PE-50 tubing for monitoring blood pressure changes using a 
pressure transducer (Narco, P-lOOB) and an MK-III Narco physiograph C^arco 
Instrument Texas, USA). The external jugular vein was similarly cannulated to 
facilitate intravenous (i.v.) injection. 
A dose of TML-1 was dissolved in 0.1 ml of normal saline and injected 
intravenously via the jugular vein into a rat. Saline (0.2 ml) was then used to flush 
the cannula. When the mean arterial pressure (MAP) was stable, another dose of 
TML-1 was applied. Thus the MAP changes to cumulated doses of TML-1 ranging 
from 0.3 to 10 mg/kg body weight (8.1 nmol-270 nmol/kg) were obtained. Doses of 
0.3, 1, 3, 6，8 and 10 mg/kg body weight of TML-1 were administered into 
c ， 
individual rats respectively and the MAP changes were recorded (Shum and Chiu, 
1991). To test whether lactose was capable of reversing the effect of TML-1 on 
blood pressure, TML-1 was preincubated with 0.1 M lactose for 1 h at room 
temperature and then the hypotensive response was determined. The MAP was the 
average pressure throughout each cycle of the heart. It can actually be determined by 
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integrating the area of the pressure curve. For simplicity, it was approximately equal 
to the summation of diastolic pressure and one-third of the pulse pressure which was 
the difference of systolic and diastolic pressures (Kelman, 1979; Sperelakis and 
Banks, 1993). 
5.2.3. Study employing blockade of autonomic ganglion transmission 
TML-1 was injected i.v. via the external jugular vein at the dose o f 3 mg/kg 
body weight (81 nmol/kg) and the MAP change served as the control. 
Hexamethonium (Sigma, USA), an autonomic ganglion blocker, was then injected 
i.v. at a dose of 28 ^imol/kg body weight. After the blood pressure was depressed 
under the influence of the blocker and stabilized, the same dose of TML-1 was 
injected again. Subsequently the change in MAP was recorded and then compared 
with the control (Chiu et al., 1995). 
5.2.4. Study employing alpha-adrenergic blockade 
TML-1 (3 mg/kg body weight) was injected and the MAP change served as 
the control. This was followed by an injection of methoxamine (0.6 ^imol/kg, Sigma, 
� USA), an agonist of a-adrenoceptor. Blockade of a-adrenoceptor was achieved 
with phentolamine (6.3 ^imol/kg, Sigma, USA). As soon as the MAP became steady, 
the same dose of methoxamine was administered again to ensure blockade of the a -
adrenoceptor. If the pressor efFect was blocked, TML-1 was administered 
immediately and the MAP changes were recorded (Ho et al., 1989). 
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5.2.5. Study employing beta-adrenergic blockade 
The method was similar to that used in testing a-adrenergic activity but the 
agonist employed was isoproterenol (l.2 nmol/kg, Sigma, USA) and the antagonist 
was propranolol (6.8 ^imol/kg, Sigma, USA) instead. 
5.2.6. Study employing cholinergic blockade 
The procedure was similar to the aforementioned procedure employing 
adrenergic blockade. Acetylcholine (Sigma, USA) acted as the neurotransmitter in 
the peripheral nervous system. Its direct effect was vasodilation and it served as an 
agonist at a dose of 11 nmol/kg. Rats were then treated with atropine (3 ^mol/kg, 
Sigma, USA), an acetylcholine antagonist. The effectiveness of the muscarinic 
receptor blockade was verified by a diminished response induced by the same dose 
of acetylcholine. Changes in MAP were compared with the control (Shum and Chiu, 
1991). 
5.2.7. Study employing histaminergic blockade 
The procedure was similar to that described above using adrenergic 
c blockade. Histamine (Sigma, USA), a powerful vasodepressor, was injected at a 
dose of 11 nmol/kg into a rat to induce a hypotensive response. Pyrilamine (Sigma, 
USA) and cimetidine (Sigma, USA), an Hi and H2 receptor blocker respectively, 
were injected simultaneously at a dose o f37 ^mol/kg and 60 ^imol/kg respectively. 
The blockade was checked by introducing the same dose of histamine. If the action 
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of histamine was blocked, TML-1 was given immediately (Ho et al., 1989; Hilditch 
etal.，1995; Pucci et al., 1995). 
5.2.8. Study employing inhibitor of the renin-angiotensin system 
The possible interactions between the hypotensive action of TML-1 and the 
renin-angiotensin and kinin systems were studied by using an angiotensin converting 
enzyme inhibitor, captopril. The responses of the rat to TML-1 were recorded. An 
effective dose of angiotensin 1 (0.03 nmol/kg, Sigma, USA) was injected, followed 
by captopril (Sigma, USA) infusion via the femoral vein (43 nmol/min/kg) for 30 min 
at the rate of0.077 ml/min. The MAP changes induced by TML-1 were compared 
with the MAP before infusion of captopril (Chiu et al., 1995). 
5.2.9. Preparation ofright atrium for in vilro studies 
A rat was sacrificed and the entire heart was rapidly excised and placed in 
100 ml ofKrebs-Henseleit solution (K-H solution in mM: NaCl, 115; KC1, 5; CaCb, 
2.1； NaHCO3, 25; NaH2PO4, 1.2; MgSO4, 1.2; glucose, 11) which had been aerated 
with 95% O2 and 5% CO2. The right atrium was isolated and the ends of the 
contraction axis of the atrial tissue were tied with silk threads and suspended inside a 
tissue chamber containing 10 ml o fK-H solution and aerated continuously at 37°C. 
The free end of the silk thread was used to hook up the tissue to a fixed position in 
the organ bath. The other end of the thread was connected to a force displacement 
transducer (Narco Myograph F-60). Isometric contractions were recorded on a 
Narco Physiograph (MK-III). The atrial tissue was equilibrated for 30 minutes under 
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a resting tension of 1 g before testing was conducted. TML-l was applied directly 
into the chamber and cumulative dose responses were obtained (Ho et al., 1989; 
Shum and Chiu, 1991). 
5.2.10. Preparation of aorta for in vitro studies 
A rat was sacrificed and the thoracic aorta was removed and placed 
immediately into K-H solution which was aerated with 95% O2 and 5% CO2. The 
aorta, which was trimmed free of connective tissues, was cut up into ring segments 3 
mm in length. The aortic ring was mounted in a lO-ml organ bath at 37°C containing 
K-H solution which was aerated continuously with O2 and CO2. Two stainless steel 
wire hooks were inserted through the aortic lumen; one was anchored to a stationary 
support and the other connected to a force displacement transducer fNarco 
Myograph F-60) for recording tension changes on a polygraph. The ring was 
allowed to equilibrate for 1 h at an initial resting tension of 1 g. After equilibration, 
the aortic ring was challenged three times with 10'^  M phenylephrine (Sigma, USA) 
to achieve a constant and reproducible contraction. TML-l was applied directly into 
the chamber and the responses were recorded (Fahim et al., 1994; Kim et al., 1994; 
Aloamaka et al., 1995, Wang et al., l996d). 
5.2.11. Adenosine receptor binding assays 
Bovine brain cerebral cortex was homogenized in 10 volumes (v/w) of ice-
cold Tris-HCl buffer (50 mM, pH 7.4) using a Brinkmann Polytron PT-10 (setting 6， 
15 sec.). The homogenate was centrifuged at 30,000 rpm for 10 min and the pellet 
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was resuspended in 20 vol. of the Tris-HCl buffer. This washing procedure was 
repeated twice. The crude membrane preparation was stored as a pellet at -20°C. 
For the adenosine Al receptor binding assay, the membrane pellet was 
resuspended in the same buffer to give a protein concentration of about 1 mgAnl，and 
350 i^l of the membrane preparation was then incubated with 1 nM ^H-
phenylisopropyladenosine (^-PIA, Amersham) in duplicate. The incubation was 
carried out in a total volume of500 ^1 for 1.5 h at 4°C in Tris-HCl buffer containing 
0.5 unit/ml adenosine deaminase and TML-1. Incubation was terminated by filtration 
on a glass fiber filter (Whatman GF/B) under suction. The filter was washed four 
times with 3 ml aliquots of ice-cold Tris-HCl buffer. The radioactivity retained on 
the filter was determined by liquid scintillation spectrometry. Non-specific binding 
was defined as binding in the presence of 100 |iM 2-chloroadenosine. Specific 
binding was calculated by subtracting non-specific binding from total binding (Yang 
et al., 1991). 
The procedure ofthe adenosine A2 receptor binding assay was similar to that 
of the adenosine Al receptor assay. Four hundred |al of the membrane preparation 
was incubated with 1 nM 5‘-N-ethylcarboxamido [8(n)-^] adenosine (^-NECA, 
Amersham) in duplicate. The incubation was carried out in a total volume of 500 i^l 
for 1.5 h at 25°C in the Tris-HCl buffer and TML-1. Non-specific binding was 
determined in the presence of 1 mM adenosine (Cheung et al., 1987; Thomas et al., 
1994). 
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5.2.12. EfFect of methylene blue on the hypotensive activity o fTML- l 
Methylene blue was injected intravenously into a rat at the dose of 0.7 mgyTcg 
body weight (achieving a concentration of about 20 ^iM in blood). After 10 min, 
TML-1 was administered and the MAP changes were recorded as described above 
(Martin et al., 1985; Kleha et al., 1993). 
5.2.13. Statistics 
Data were analyzed using one-way analysis of variance and matched-pair 
comparisons were further made by Student's /-test (one-tailed). The level of 
significance was taken at P < 0.05 and the data are presented as means±SEM. 
5.3. Results 
5.3.1. Blood pressure changes in vivo 
The anaesthetized rat was fixed on a surgical dissection board lying on its 
back. Upon intravenous injection ofTML-l an immediate hypotensive response was 
observed and the maximum decrease in MAP appeared about 60 seconds after drug 
injection (Fig. 5.1). The hypotensive changes were dose-dependent in the 
normotensive rats and a dose of 10 mg/kg body weight brought about a mean 
arterial blood pressure (MAP) reduction of 95.3土7.4 mmHg (Fig. 5.1, Fig. 5.2). 
Subsequently the blood pressure rose gradually but did not return to the original 
level. It was stable and reached 60% of the maximum decrease (recovery rate being 
40%) 10 min after TML-1 administration. 
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The hypotensive response to lactose-treated TML-l was not significantly 
different (P>0.05) from that of the non-treated control. 
5.3.2. Pharmacological studies using receptor antagonists 
The possible involvement of a-adrenoceptors in TML-1 mediated changes in 
MAP was studied by using methoxamine (50 |ng/kg). TML-1 (3 mg/kg or 81 
nmol/kg) produced an immediate decrease of 21.2±5.3 mmHg in MAP. When the 
same rat was then treated with methoxamine, an increase of 65.1土8.1 mmHg in 
MAP was observed. In the presence of phentolamine, the increase of MAP by 
methoxamine was reduced to 6.4土1.3 mmHg. When TML-1 was then given, the 
MAP was -37.7±5.2 mmHg which was not significantly different from the control 
(Fig. 5.3). 
In the studies on autonomic ganglion transmission, beta-adrenergic, 
cholinergic, histaminergic activities, similar results were obtained, i.e. the decrease in 
MAP in the presence of the antagonists was not significantly different from the 
control (Fig. 5.4-5.7). In the study on the renin-angiotensin system, TML-1 there 
was no difference in the hypotensive effect of TML-1 in the absence or presence of 
captopril (Fig. 5.8). 
5.3.3. Adenosine receptor binding assay 
TML_1 inhibited the binding o f ^ - N E C A to adenosine A2 receptors with an 
IC50 value (concentration required to inhibit specific binding by 50%) of 1 mg/ml. 
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However, TML-1 was devoid of any efFect on the binding of ^ - P I A to adenosine 
Al receptors within the concentration range of 0.04-4 mg/ml. 
5.3.4. Effects on the right atrium in vitro 
The basal atrial rate in SD rats was 255±18 beats/min： Changes in the artrial 
rate in response to different doses of TML-1 were not statistically significant 
(p>0.05) from those ofthe control. However, a dose-dependent decrease in the atrial 
tension was discernible. The initial atrial tension was 0.3±0.01 g, but it dropped to 
0.2土0.01 g when the concentration ofTML-1 was increased to 400 mg/1 (Fig. 5.9). 
5.3.5. EfFect ofTML-1 on vascular relaxation 
TML-1 significantly relaxed, in a concentration-dependent manner, the rat 
aortic rings which had been precontracted with phenylephrine. At the concentration 
of 140 mg/1, the relaxation achieved was 93.2土7.3% (Fig. 5.10). 
5.3.6. EfFect ofmethylene blue on the hypotensive activity ofTML-1 
Methylene blue markedly suppressed the hypotensive response ofTML-1. At 
the dose of0.7 mg/kg body weight, the inhibition rate was 72.6%. 
5.4. Discussion 
TML-1 is a protein purified from Tricholoma mongolicum which has 
hemagglutinating activity as described in Chapter 3. The present study demonstrated 
a hypotensive effect of TML-1 in the normotensive rats upon intravenous injection. 
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This is in accord with various reports on the hypotensive effects of other edible 
mushrooms (Tam et al., 1986; Adachi et al., 1988，Chiu et al., 1995). TML-l 
possessed a potent hypotensive efFect: a typical dose of 10 mg/kg body weight o f the 
rat decreased the MAP by 95.3±7.4 mmHg. The lowered blood pressure did not 
return to the original level indicating a sustained hypotensive effect. Howener, other 
causes such as irreversible damage to cardiac contractility and the vascular smooth 
muscle at certain sites are also possible. The hypotensive activity ofTML-1 was not 
attenuated by lactose, indicating that different domains of the molecule may be 
responsible for hemagglutinating and hypotensive activities (Kleha et al., 1993). 
However, TML-2, another lectin isolated from this edible mushroom, exhibited little 
hypotensive activity, and the treated rats died when the dose given by intraveneous 
injection exceeded 3 mg/kg, A polysaccharide-peptide complex isolated from same 
mushroom (Wang et al., 1996b) did not exhibit any hypotensive action. 
As judged by the results obtained from the pharmacological studies, the 
hypotensive effect ofTML-1 was not mediated via autonomic ganglion transmission, 
a-adrenoceptors, beta-adrenoceptors, cholinergic and histaminergic activities, nor 
the renin-angiotensin system. However, TML-l brought about a significant 
relaxation of the rat aortic rings and its hypotensive activity was abolished by 
methylene blue. 
It has been reported that some lectins could lower the blood pressure by 
enhancing the release ofendothelium-derived relaxing factor (EDRF) which is a very 
labile compound with rapid biological action (Kleha et al., 1991, 1993). It was 
believed that the major EDRF released from the endothelium was nitric oxide (Fahim 
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et al.，1994). Vascular responses to EDRF were ascribed to the stimulation of 
guanylate cyclase, which, by increasing smooth muscle guanosine 3':5'-cyclic 
monophosphate (cyclic GMP) levels, causes smooth muscle relaxation (Kleha et al., 
1993; Christiansen et al., 1994). Methylene blue appeared to inhibit selectively 
vasorelaxation induced by agents which increase cyclic GMP levels. It might 
produce its effects by oxidizing a component of guanylate cyclase, possibly a ferrous 
heme group linked to the enzyme molecule. Methylene blue might, in addition, 
interact directly with EDRF (lgnarro et al., 1984; Martin et al., 1985; Gryglewski, 
1995). TML-1 stimulated in inice the production of nitric oxide by macrophages 
(Wang et al.’ 1996a) and efTectively relaxed rat aortic rings which had been 
precontracted with phenylephrine in the present study. Methylene blue was shown to 
antagonize the hypotensive activity of TML-1, suggesting that the mechanism of 
action ofTML-1 on the blood vessels may involve nitric oxide. 
In further study, both intact and denuded (endothelial cells were removed) 
aortic rings, L-N-nitro arginine (a nitric oxide synthase inhibitor) and methylene blue 
(a guanylyl cyclase inhibitor) will be used for determination of effects of TML-1 on 
the production of EDRF (Martin et al., 1985; Chiou et al.，1994). As Ca�+ ions play 
an important role in muscular contraction, the efFect of TML-1 on calcium channel 
need to be studied also (Chiou et al., 1991; 1992). The models of genetically 
hypertensive rats or other hypertensive animals will be used instead of the 
normotensive rats. Other routes of administration by which TML-1 is given, such as 
by oral feeding or introperitoneal injection, will be studied. . 
« 
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Adenosine is a putative neurotransmitter in the central and peripheral nervous 
systems. It influences many biological processes including reduction of renin release, 
sedation, inhibition of platelet aggregation, bronchoconstriction and vasodilatation 
(Cheung et al., 1987; Yang et al., 1991). It has been suggested that adenosine may 
exert its effect by modulating the transmembrane calcium flux in nerve terminals and 
smooth muscle. Two distinct classes of adenosine receptors, namely A1 and A2 
receptors, have been identified in the maminalian system (Fahim et al., 1994). A1 
receptors have been identified in the atria and adrenergic and cholinergic nerve 
terminals and A2 receptors mainly in the blood vessels. In general, adenosine 
analogues with preferential atTinity lo A1 receptors produce depression in heart rate 
and cardiac contractility while analogues with affinity for A2 receptors cause 
vasodilatation (Thomas et al., 1994). TML-1 significantly inhibited 'H-NECA 
binding to bovine cerebral cortical adenosine A2 receptors but it exerted no effect on 
the binding of 'H-PlA to adenosine A1 receptors. As TML-1 produced a marked 
relaxing effect on the rat aortic rings which had been precontracted with 
phenylephrine, it is possible that this was the result of its interaction with A2 
receptors. In turn, it may account for the hypotensive response in the rat. However, 
it must be born in mind that brain tissure instead of vascular tissue was used in the 




A lectin, designated as TML-1, which exerted a hypotensive action in the rats 
after intravenous injection via the jugular vein, was isolated from the mycelia o f the 
edible mushroom Tricholoma mongolicum. The hypotensive changes produced by 
TML-1 were dose-dependent. Administration of TML-1 at a dose of lO mg/kg body 
weight caused a mean arterial blood pressure (MAP) reduction of 95.3土7.4 mmHg. 
The hypotensive action of TML-1 was not mediated via autonomic ganglion 
transmission, a-adrenoceptors, beta-adrenoceptors, cholinergic receptors, 
histaminergic receptors, nor the renin-angiotensin system. Rather it was probably 
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Figure 5.2. Dose-response curve of the hypotensive effect of TML-1 in male 
Sprague-Dawley rats. Vertical bars represent SEM. MAP before injection 
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Figure 5.3. EfTect of blockade of alpha-adrenergic activity on the hypotensive 
e(Tect of TML-1 in male Sprague-Dawley rats. TML-1 and drugs were 
administered in the following sequence: TML-1, 81 nmol/kg; 
methoxamine, 0.6 nmol/kg; phentoIamine, 6.3 |,imol/kg; methoxamine, 0.6 
|_imol /kg; and TML-1, 81 nmol/kg. The significant difference in MAP 
increase between the responses to the first and second injections of 
methoxamine indicated tliat the a-adrenoceptor was blocked by 
phentoIamine. The MAP changes induced by the second injection of 
TML-1 over the corresponding control were similar to that brought about 
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Figure 5.4. EfFect of blockade of autonomic ganglion transmission on the 
hypotensive efFect of TML-1 in male Sprague-Dawley rats. TML-1 and 
drugs were administered in the following sequence: TML-1, 81 nmol/kg; 
hexamethonium, 28 ^imol/kg; and TML-1, 81 nmol/kg. The MAP changes 
induced by the second injection of TML-1 over the corresponding control 
were�similar to that brought about by the second TML-1 injection. 
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Figure 5.5. Effect of blockade of beta-adrenergic activity on the hypotensive 
effect of TML-1 in male Sprague-Dawley rats. TML-1 and drugs were 
administered in the following sequence: TML-1, 81 nmol/kg; 
isoproterenol, 3.3 nmol/kg; propranolol, 6.8 ^imol/kg; isoproterenol, 3.3 
nmol/kg; and TML-1, 81 nmol/kg. The significant difference in MAP 
decrease between the responses to the first and second injections of 
isoproterenol indicated that the P-adrenoceptor was blocked by 
isoproterenol. The MAP changes induced by the second injection ofTML-
1 over the corresponding control were similar to that brought about by the 
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Figure 5.6. Effect ofblockade of cholinergic activity on the hypotensive effect of 
TML-l in male Sprague-Dawley rats. TML-l and drugs were 
administered in the following sequence: TML-l, 81 nmol/kg; 
acetylcholine, 11 nmol/kg; atropine, 3 ^mol/kg; acetylcholine, 11 nmol/kg; 
and TML-l, 81 nmol/kg. The MAP changes induced by the second 
injection of TML-l over the corresponding control were similar to that 
brought about by the second TML-l injection. Results are presented as 
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Figure 5.7. Effect ofblockade ofhistaminergic activity on the hypotensive effect 
of TML-1 in male Sprague-Dawley rats. TML-1 and drugs were 
administered in the following sequence: TML-1, 81 nmol/kg; histamine, 
11 nmol/kg; pyrilamine and cimetidine, 37 ^imol/kg and 60 ^mol/kg 
respectively; histamine, 11 nmol/kg; and TML-1, 81 nmol/kg. The MAP 
changes induced by the second injection ofTML-1 over the corresponding 
control were similar to that brought about by the second TML-1 injection. 
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Figure 5.8. Effect of blockade of renin-angiotensin system on the hypotensive 
effect o fTML- l in male Sprague-Dawley rats. TML-1 and drugs were 
administered in the following sequence: TML-1, 81 nmol/kg; angiotensin 
I’ 0.03 nmol/kg; captopril, infusion via the femoral vein at the rate of 
0.077 ml/min (46 nmol/miny'kg) for 30 min; angiotensin I，0.03 nmol/kg; 
and TML-1, 81 nmol/kg. The MAP changes induced by the second 
injection of TML-1 over the corresponding control were similar to that 
brought about by the second TML-1 injection. Results are presented as 
means 士 SEM (n = 5). 
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Figure 5.9. Inotropic effect ofTML-1 on right atria isolated from male Sprague-
Dawley rats. The atrial tissue was placed under a resting tension of 1 
gram, and equilibrated for 30 min before testing was conducted. Results 
are presented as means 士 SEM (n = 5). 
133 
• 
100 J T 
,^^ 
8 0 - T ^ ^ 
1 6 ° j f 
S) / 
I 4 0 - / 
<u / 
I / 
20 一 d 
0 ^ 
1 1 ~1 1 1 n i I “ “ 
0 20 40 60 80 100 120 140 
TML-1 (mg/L) 
Figure 5.10. Dose-response curve of the effect of TML-1 on relaxation of 
phenylephrine-contracted rings from Sprague-Dawley rats. The ring was 
allowed to equilibrate for 1 h under an initial resting tension of 1 gram 
and it was challenged three times with 10'^ M phenylephrine to achieve a 
constant and reproducible contraction. Results are presented as means 士 
SEM(n = 5). 
CHAPTER 6 
A Polysaccharide-Peptide Complex with Immunoenhancing and Antitumor 
Activities from Cultured Mycelia of the Mushroom Tricho1oma nioii^oHcum 
6.1. Introduction 
Polysaccharides or prolein-bound polysaccharides of fungal origin have been 
found to effectively inhibit growth ofimplanted Sarcoma 180 in mice. These include 
schizophyllan (Jong et al., 1991), lentinan (Chihara et al., l%9; Maeda and Chihara, 
1971; Chihara, 1992; Ochiai et al., 1992), PSK (Kim et al., 1990; Sakagami et al., 
1991； Tsuru et al., 1991), polysaccharopeptide (PSP) (Yang et al., 1992; Liu et al., 
1993a), glucan components (Suzuki et al., 1989; Kwang et al., 1992) and PSPC (Liu 
et al., 1995; Wang et al., 1995a). The antitumor activity is believed to be a 
consequence of stimulation of the cell-mediated iminune response which involves . 
macrophages, natural killer cells, cytotoxic T cells and their secretory products 
including tumor necrosis factor, reactive nitrogen and oxygen intermediates, and 
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interleukins (Adachi et al., 1987; Chihara, 1992; Kim et al., 1992; Ohno et al., 
1996). 
In the present study, a polysaccharide-peptide complex, designated TMP, 
with more potent antitumor and immunoenhancing activities than PSP, a commercial 
preparation of the mushroom Coriolus versicolor polysaccharopeptide (Yang et al., 
1992) was isolated from the submerged mycelial culture of Tricholoma mongoUaim. 
6.2. Materials and Methods 
6.2.1. Extraction 
The mycelia of 7： mon^oHcum was cultured as described in Chapter 3 ofthis 
thesis. After 9 days, the culture was homogenized and heated at the boiling 
temperature for six hours. The filtrate obtained after filtration was concentrated in a 
rotavapor before lyophilization. The resulting lyophilized powder was designated as 
crude powder. 
6.2.2. Purification 
Crude powder was subjected to ion exchange chromatography on a DEAE-
Sepharose CL-6B column (1.0 x 22 cm) which was equilibrated with 5 mM and 
then eluted successively with 5 mM, 50 mM, 150 mM and 1 M ammonium 
bicarbonate buffer (pH 9.0) (Wang et al., 1995a). The chromatographic fractions 
were lyophilized and designated F1, F2, F3 and F4 respectively. Fl was found to be 
« 
the most biologically active one among these fractions and designated TVTP. 
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6.2.3. Polysaccharopeptide (PSP) for purpose of comparison 
Polysaccharopeptide isolated from the deep-layer cultivated mycelia of 
Coriolus versicolor was purchased from Winsor Health Products Ltd., Hong Kong 
(Yang et al., 1992; Liu et al., 1993a). 
6.2.4. Polysaccharide and protein contents 
The carbohydrate and protein contents of chromatographic fractions derived 
from the crude powder were estimated by the anthrone and Lowry methods 
respectively (Lowry et al., 1951;Chang et al., 1988). 
6.2.5. Molecular weight determination ofFl using gel filtration 
It was carried out on a Sephadex G-lOO column (1.0 x 75 cm) which was 
eluted with 50 mM ammonium bicarbonate buffer (pH 9.0). The standard protein 
markers used included cytochrome C (MW 12,400), chymotrypsinogen A (MW 
25,000), egg albumin (MW 45,000) and bovine serum albumin (MW 67,000). Blue 
dextran was used for determination of the void volume (Kiho et al., 1992a; Kim et 
al., 1992). 
6.2.6. Animals 
The male inbred C57BL/6 and BALB/c mice used in this study were kept 
under 21±2°C and a 12/12 h light/dark cycle, and maintained on standard rodent 
chow ad lihiwni. For determination of mitogenic activity in vivo, production of 
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nitrite ions (NO2') and macrophage activating factor, the C57BL/6 mice were 
pretreated by force feeding using a stomach tube with a solution (10 mg/ml) of the 
crude powder, fraction 1 and PSP respectively at the dosage of 50 mg/kg body 
weight/day for 7 days. The control group was similarly treated with PBS buffer (pH 
7.2). For determination ofinitogenic activity in vilro, BALB/c mice were used. 
6.2.7. Antiproliferative activity assay 
Tumor cell lines including Sarcoma 180 (mouse sarcoma), H3B (human 
cellular hepatoma) and PU5-1.8 (mouse monocyte-macrophage) were cultured at 1 x 
10^ cells/0.2 ml/well in the presence of a serial two-fold dilution of the crude 
powder, or the chromatographic fractions F1 to F4 (0，3, 6, 12’ 25 and 50 ^g/ml) for 
24 h before they were pulsed with 0.5 ^iCi/10 |al/well of 'H-methyl-thyiTiidine for 6 
h. The uptake of the radioisotopes by the tumor cells was measured with a liquid 
scintillation counter (Liu et al., 1989). 
6.2.8. Mitogenic activity 
/" vitro study. T-cells were purified from the normal murine splenocytes in 
flasks coated with anti-B cell antibodies as described in Chapter 4. The T-cells were 
diluted with RPM1 medium containing 10% fetal bovine serum and then seeded (2 x 
106 cells/well/0.2 ml) in 96-well microplates. The crude powder, its chromatographic 
fractions (Fl_F4) and PSP were each introduced at the concentrations ofO, 6，12, 25 
and 50 ^ig/ml. Cells cultured in the absence of mycelial extracts served as control 
(CTL). The cells were incubated at 37�C in a humidified atmosphere of 5% CO2 for 
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48 h. During the last 6 h, the cells were pulsed with 0.5 fiCi/10 ^il/weIl of "^H-methyl-
thymidine (specific activity 5 ^iCi/mmole, Amersham, England). The cells were then 
harvested onto a glass fiber filter using a cell harvester, and the radioactivity was 
determined using a Beckman scintillation counter. The proliferative response was 
expressed as mean counts per minute (CPM). The mitogenic activities of the crude 
powder, Fl-F4 and PSP toward splenocytes were determined as T-cells (Liu et al., 
1996b). 
7// vivo study. T-cells were isolated as in the i" vilro study from the mice, 
which however had been pretreated with the cmde powder, fraction 1 or PSP 
(maintenance and procedure were the same as that described under the heading 
"Animals"). Their mitogenic response was determined as described above with the 
addition ofconcanavalin A (Con A) (I<iho et aI., 1992b). 
6.2.9. Production of nitrite ions 
Peritonea! macrophages were collected, 3 days after eliciting by 
thioglycolate, from the mice which had been pretreated with the crude powder, 
fraction 1 material or PSP. The cells were washed, counted and resuspended in 
DMEM medium and the method of nitrite ion determination was the same as that 
described in Chapter 4. 
6.2.10. Macrophage activating factor assay 
Assay of the tumoricidal activity of macrophage activating factor-activated 
macrophages was carried out as detailed by Liu et al. (1989) and as described in 
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Chapter 4 but the peritoneal cells were collected from the mice which had been 
pretreated with the crude powder, fraction 1 material or PSP. 
6.2.11. Antitumor activity assay 
Sarcoma 180 cells were inoculated into the back of every BALB/c mouse as 
described in Chapter 4. The tumor-bearing mice were treated after inoculation in 
accordance with the procedure described under the heading "Animals" with the 
solution (10 mg/ml) of the crude powder, fraction 1 material and PBS forlO days at 
the dosage of 50 mg/kg/day after inoculation of tumor cells. On the 21th day, the 
mice were sacrificed and their solid tumors were excised and weighed. The tumor 
inhibition activity of the administered substance was calculated as described in 
Chapter 4. 
6.2.12. Statistics 
Data were analyzed using one-way analysis of variance and matched-pair 
comparisons were further made by Student's /-test (one-tailed). The level of 




6.3.1. Purification of polysaccharide-peptide complex 
Four peaks, F1, F2, F3 and F4, were observed after anion-exchange 
chromatography of the crude powder on DEAE-Sepharose CL-6B (Fig. 6.1). The 
ratios of their carbohydrate and protein contents are presented in Table 6.1. 
6.3.2. Antiproliferative activity 
Table 6.2 shows the ^-methyl-thymidine uptake by tumor cells of various 
origins after treatment with the crude powder, materials from F1 to F4. No 
significant difference (P > 0.05) from the control was observed in the various tumor 
cells after treatment. 
6.3.3. Mitogenic activity /// vHro 
Among the substances tested for mitogenic activity toward T-cells including 
crude powder, its chromatographic fractions and PSP, only fraction 1 markedly 
enhanced the proliferation ofT-cells from both normal C57BL/6 and BALB/c mice 
(Fig. 6.2). The crude powder, chromatographic fractions F2-F4 and PSP did not 
enhance the proliferation ofT-cells over the concentration range of 6-50 ^ig/ml. The 
results of the mitogenic response of splenocytes toward the crude powder, materials 
from Fl-F4 and PSP were similar to those ofT-cells (Fig. 6.3). So the fraction 1 was 
chosen for the further study. 
• 
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6.3.4. Molecular weight o fF l 
The molecular weight of F1 was 15,500 as judged by gel filtration on 
Sephadex G-lOO (Fig. 6.4). 
6.3.5. Mitogenic activity in vivo 
The proliferation ofT-cells was significantly stimulated by the crude powder, 
F1 and PSP when compared with the control. F1 appeared to be more potent than 
PSP, especially when the concentration ofCon A used was 10 ^ig/ml (Fig. 6.5). 
6.3.6. Productionofnitriteions 
Nitrite ions production by the peritoneal macrophages of C57BL/6 mice 
upon LPS stimulation was considerably higher, after pretreatment with the crude 
powder, F1 or PSP, than that of the butTer-treated control. The response to F1 was 
significantly higher than that to PSP (Fig. 6.6). 
6.3.7. Production of macrophage activating factor 
In order to estimate the ability of the crude powder, F1 and PSP to stimulate 
mouse macrophages, an /// vivo assay for the inhibition of tumor cell growth by 
activated macrophages was used (Figure 6.7). For the Fl-treated group, when the 
ratios ofmacrophage : P815 employed were between 5 : 1 and 40 : 1, the growth of 
tumor cells was significantly (P < 0.05) inhibited, in other words, the tumoricidal 
activity was higher as compared with the control, cmde powder-treated and PSP-
• 
treated groups. When the ratio of macrophage : P815 was raised to 40 : 1, all 
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experimental groups as well as the control group possessed higher tumoricidal 
activities than the activities observed at lower macrophage : P815 ratios (i.e. 5 : 1, 
10 : 1 and 20 : 1). The tumoricidal activities of crude powder-treated and PSP-
treated groups were more potent than that of control when the ratios ofmacrophage 
:P815 were used between 5 : 1 and 20 : 1. 
6.3.8. Antitumor activity iii vivo 
The effects ofcrude powder and F1 against Sarcoma 180 growth in BALB/c 
mice are presented in Table 6.3. The percentage ofinhibition achieved by the crude 
powder and F1 was 33.60% and 67.19% respectively. 
6.4. Discussion 
ln the present investigation, a polysaccharide-peptide complex (TMP) with a 
carbohydrate : protein ratio of 8.15 : 1 was isolated from cultured mycelia of the 
mushroom T. mon^oIiciim. The complex was unadsorbed on the anion exchanger 
and possessed a molecular weight of 15,500. It exhibited a higher potency than the 
crude powder, from which it was derived, in inhibiting the growth of Sarcoma ]80 
cells in mice. Besides antitumor activity, it also had immunostimulating activity as 
evidenced by its ability to stimulate T-cell proliferation, nitrite ions production by 
macrophages, and production of macrophage activating factor and hence inhibition 
ofP815 mastocytoma cells. At the concentration of3-50 |ag/nil, the crude powder, 
F1 F2 F3 and F4 did not markedly inhibit the /.// vi/ro growth of several tumor cell 
lines including Sarcoma 180, H3B and PU5-1.8, despite the antitumor activity of the 
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crude powder and Fl against Sarcoma 180 i" vivo. All of these data indicated that 
the crude powder and Fl were iinmunomodulatory substances rather than substances 
exerting direct cytotoxicity. The antitumor activity against Sarcoma ]80 was 
probably a consequence of immunostimulation and not a result of direct 
antiproliferative activity (Sakagami et al., 1991; Mizuno et al., 1995b). 
When the T. mongo/iciim polysaccharide-peptide complex (TMP) is 
compared with PSP, its counterpart from the mushroom C()ri()his vcrsici/or (Yang 
et al., 1992), it can be seen that the former has a much smaller molecular weight 
(MW ofPSP = 100,000) and a higher carbohydrate to protein ratio (that ofPSP = 
5.7 : 1). TMP also exerted more potent antitumor and imnuinostimulatory activities 
than PSP did. PSP brought about 52% and 38% inhibition ofSarcoma 180 growth in 
ICR mice at the thineenlh and twenty-first day respectively when the mice were 
inoculated with 1 x 10(’ tumor cells and the oral dosage of PSP was 1000 mg/kg 
body weight/day for 10 days (Yang et al., 1992). PSP also induced a less dramatic 
increase in T-cell proliferation and production of nitrite ions and macrophage 
activating factor by macrophages (Liu et al., 1993a) than that ofTMP. 
The chemotherapy of cancer is restricted in effectiveness (Chihara, 1992; 
Ochiai et al., 1992) and may have harmful side-efTects such as immunosuppressive 
effects (Tsuru et al., 1991). In view of its imnuinostimulatory and antitumor 
activities, the polysaccharide-peptide complex from 丁. mon^oHcnm may be a 




A polysaccharide-peptide complex (TMP) with immunoenhancing and 
antitumor activities was isolated from the mycelial culture of Tricholoma 
mongoliciim by a method involving extraction with boiling water, ion exchange 
chromatography on DEAE-Sepharose CL-6B and gel filtration on Sephadex G-100. 
It possessed a molecular weight of 15,500 as estimated by gel filtration and a 
carbohydrate : protein ratio of approximately 8 : 1, and it was not adsorbed on 
DEAE-Sepharose CL-6B. lt possessed the activities of activating macrophages, 
stimulating proliferation of T-cells, and inhibiting the growth of Sarcoma 180 cells 
which had been implanted in mice. 
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Table 6.1 _ The carbohydrate to protein ratios of DEAE 
chromatographic fractions Fl-F4 
Fi F2 n F4 
Carbohydrate /~~8,15 : 1 0.19 : 1 0.15 : 1 0.39 : 1 ~~" 
Protein ratio 
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Table 6.2. Effect of crude powder (CP) and FJ-F4 on 'H-methyl-
thymidine uptake by various tumor cell lines 
Dose Tumor cell line 
(fAg/ml) PU5-1.8 S-180 H3B 
0 28440±3351 63458±4864~~~. 53274±4982 
CP 12 31563±2849 70029±7421 5841114654 
50 27643±2130 71457±53]8 57309i3847 
0 26284i3015 69259i4047 60173±5039 
F1 12 30273±1852 68424±4840 58416±2760 
50 3032511734 68616±38丨丨 57389±3715 
0 27614±2149 72048±6473 57426±5543 
F2 12 26107t3137 71263±5299 5%12±4671 
50 28763±1980 70721±5316 60151±4160 
0 34541±3012 6831714213 60869t2845 
F3 12 33249±1878 6518315109 57384±3842 
50 32568±2156 66025±3765 56416±1947 
0 27643±2247 69310±2750 57472±1302 
F4 12 29001±2309 68248±1067 59387±2943 
50 27888±3712 68080±34丨丨 58493±3317 
Results are presented as mean 土 standard deviation (n = 3). 
• 
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Table 6.3. Antitumor activities of crude powder (CP) and F1 
against Sarcoma 180 
C Y L CT F\ 
Average tumor l J ^ L ^ 0.83* 
weight (g) ±1.21 ±1.01 ±0.71 
Inhibition oftumor 0 33.60 67.19 
growth (%) 
* Level ofsignificance at P < 0.05. The data are presented as mean 
士 standard deviation. N = 10 mice/group and CTL = control. 
J 4 S 
• 
2.5 j 
f F l - j 
i 1.5 -
_ F4 
§ i - _ i h 
� F2 F3 1 
叫 1 j w J V 
0 u ~ i ^ T " f " P ^ ^ ^ ^ " " ^ ^ ^ ~ I ~ ~ T ' W I ^ ^ V p 
0 10 20 30 40 50 60 70 80 90 100 110 
Elution volume (ml) 
Figure 6.1. Fractionation of crude powder on a DEAE-Sepharose CL-6B 
column (1.0 x 22 cm). The column was eluted stepwise with 5 mM 
(elution volume 0-28 ml), 50 mM (elution volume 29-52 ml), 150 mM 
(elution volume 53-84 ml) and 1 M (elution volume 85-115 ml) 
ammonium bicarbonate buffer (^H 9.0). 
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Figure 6.2. In vitro mitogenic activities of crude powder, Fl-F4, and PSP at the 
concentrations of 6-50 figAnl on T-cells from normal BALB/c mice. The 
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Figure 6.3. In vitro mitogenic activities of crude powder, Fl-F4, and PSP at the 
concentrations of 6-50 ngAnl on splenocytes from normal BALB/c mice. 




i ^ y ^ ^ ^ ^ - ^ - - ^ ^ 
g (2). ^ - - ^ . . . , , _ ^ ^ 
I (^^^"""^""^^"^^""^^^^ 





1 ] 1 1 1 1 i 1 1 1 1 
1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 2 
Ve/Vo 
Figure 6.4. Gel filtration o f F l on a Sephadex G-lOO column (1.0 x 75 cm). The 
molecular weight markers used were: (1) bovine serum albumin (MW 
67,000)，（2) egg albumin (MW 45,000), (3) chymotrypsinogen A (MW 
25，000) and (4) cytochrome C (MW 12,400). The molecular weight o f F l 
was 15,500. Ve 二 elution volume and Vo = void volume. 
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Figure 6.5. Mitogenic response of T-cells from C57BL/6 mice which had been 
pretreated by force feeding with cmde powder (CP), F1 or PSP at 50 
mg/kg body weightAiay for 7 days. The data are presented as mean 士 
standard deviation. * P < 0.05 (against respective control, n = 6). 
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Figure 6.6. Production of NO2' by macrophages of C57BL/6 mice which had 
been pretreated by force feeding with crude powder (CP), Fl or PSP at 50 
mg/kg body weightAiay for 7 days. The data are presented as mean 土 
standard deviation. * P < 0.05 (against respective control, n = 6). 
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Figure 6.7. Tumoricidal activity of macrophage activating factor-activated 
macrophages from C57BL/6 mice which had been pretreated with crude 
powder (CP), F1 or PSP. The data are presented as mean 土 standard 
deviation (n = 6). 
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General Discussion 
Mushrooms have long been appreciated for their flavor and texture, and 
some mushrooms have also been treasured traditionally for their medicinal and tonic 
attributes. They are indeed nutritionally a very good food and more recently they 
have been proved to be an important potential source of biologically active 
compounds of medicinal value (Jong et al., 1991; Mizuno et al., 1995b). The 
application of modern analytical techniques has provided a scientific basis for the 
earlier empirical observations and traditional usages. Recently a new term 
"mushroom nutriceutical” has been suggested. A mushroom nutriceutical is a 
refined/partially refined mushroom extract which is consumed in the form of capsules 
or tablets as a dietary supplement (not a food), and which has potential therapeutic 
applications. A regular intake may enhance the immune response of the human body 
thereby increasing resistance to disease and, in some cases, cause regression of a 
disease state (Chang and Buswell, 1996). 
The results of the present study indicate that the famous edible wild 
• 
mushroom Tricholoma ivoii^ohcmv possesses potent medicinal activities in addition 
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to its flavor and texture. Two distinct lectins, designated as TML-1 and TML-2, 
have been isolated and purified from the cultured mycelium of the T. niongolicnm. 
They exhibit antiproliferative activities against several tumor cell lines in vitro, for 
example mouse monocyte-macrophage PU5-1.8 cells and mouse mastocytoma P815 
cells. They stimulate the production of nitrite ions by macrophages in the normal and 
tumor-bearing mice. These lectins enhance the production of tumor necrosis factor 
by macrophages. Both TML-1 and TML-2 are able to inhibit the growth of 
implanted Sarcoma 180 cells in mice by 68.8% and 92.4% respectively. The growth 
of Sarcoma 180 cells in the peritoneal cavity of mice is inhibited and the life-span 
was prolonged by the two lectins. 
TML-1 exerts a hypotensive response in the nonnotensive rats after 
intravenous injection via the jugular vein. The blood pressure changes produced by 
TML-1 are close dependent. The hypotensive action is probably mediated through 
vasorelaxation via adenosine A2 receptors and/or nitric oxide production. 
A polysaccharide-peptide complex with immunostimulating and antitumor 
activities has also been isolated from the mycelial culture of 7: mongoHcnm. lt 
exhibits the activities of activating macrophages, enhancing the proliferation of T-
cells and inhibiting the growth of Sarcoma 180 cells that had been implanted in mice 
subcutaneoLisly. 
The immunornodulatory and hypotensive activities of the components of T. 
mongolicum have made this mushroom a potential neutriceutical source for the 
human, especially for the old people. In the ageing persons, the elasticity of the 
« 
arteries has diminished. As a result the heai1 must pump forcibly, thereby leading to 
157 
a rise in systolic pressure. On the other hand, inany immune parameters linearly 
deteriorate with age and an impairment of the immune system could lead to an 
increased incidence of infectious, neoplastic and autoimmune diseases in the elderly 
(Bartoloni et al., 1991; Sansoni et al., 1993). Intake of nutriceutical products of T. 
mongoliaim may help to improve their cardiovascular performance and enhance 
their immune defence system. 
The results of the present study indicate that TML-1 and TML-2 and the 
polysaccharide-peptide complex isolated from 7: mon^oHcum deserve further studies 
for development as a potential nutriceutical as well as potential agents for cancer 
therapy or an immun0m0dulat017 adjuvant for chemotherapy. TML-1 may be used 




1. Two lectins, TML-1 and TML-2, were isolated from the cultured mycelium of 
Tricholoma nion^oHcnm, an edible mushroom found in Northern China, by ion 
exchange chromatography and gel filtration. 
2. They were dimers with molecular weights near 37,000. The hemagglutinating 
activities of TML-1 and TML-2 were sensitive to lactose inhibition and were 
stable between 10�and 80°C. 
3. TML-1 and TML-2 did not differ appreciably in their pH stability and cationic 
requirement for hemagglutinating activity. 
4. The two lectins differed in the content of proline and tyrosine residues. Both 
were nonglycoproteins but contained some hydroxyproline residues. 
5. TML-1 and TML-2 exhibited antiproliferative activities against mouse 
monocyte-macrophage PU5-1.8 cells and mouse mastocytoma P815 cells in 
vitro but did not inhibit the growth of mouse Sarcoma 180 and mouse 
monocyte-macrophage P388D1 tumor cell lines. 
6. Both lectins stimulated the production of nitrite ions by activating macrophages 
in mice which had been pretreated with TML-1 or TML-2. • 
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7. The two lectins were able to inhibit the growth of implanted Sarcoma 180 cells 
by 68.8% and 92.4% respectively. The growth of tumor cells in the mouse 
peritoneal cavity was also suppressed by the two lectins with TML-2 expressing 
a greater potency. 
8. TML-1 possessed hypotensive activity in the normotensive rats and at the dose 
of 10 mg/kg body weight caused a mean arterial blood pressure (MAP) 
reduction of95.3±7.4 mmHg. 
9. Asjudged from the results of pharmacological studies, the hypotensive action of 
TML-1 was not mediated via autonomic ganglion transmission, a -
adrenoceptors, beta-adrenoceptors, cholinergic receptors, histaminergic 
receptors, nor the renin-angiotensin system. Rather it was probably mediated 
through relaxation of the aorta via adenosine A2 receptors. 
10. A polysaccharide-peptide complex with immunoenhancing and antitumor 
activities was also obtained from the mycelial culture of 7! moii^oliciim. 
11. The polysaccharide-peptide complex had a molecular weight of 15,500 as 
estimated by gel filtration and a carbohydrate : protein ratio of approximately 8 : 
1. lt was not adsorbed on DEAE-Sepharose CL-6B. 
12. TML-1, TML-2 and the polysaccharide-peptide complex deserve to be studied 
as potential agents for immunomodulation and cancer therapy. TML-1 may be 
used as a hypotensive drug after further research. 
13. T. wongo/iciim could be used as a nutriceutical as well as a food. 
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